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ABSTRACT
CYTOTOXICITY AND CELLULAR RESPONSE TO a,~-UNSATURATED
ALDEHYDES. ROLE OF ALDEHYDE DEHYDROGENASES

Ngome Makia
August 24, 2011
The lipid aldehydes, 4-hydroxy-2-nonenal (4-HNE) and propene-2-al (acrolein) are
reactive

a,~-unsaturated

aldehydes generated during the peroxidation of lipids and are

implicated in the pathogenesis of several oxidative-stress mediated diseases, including
steatohepatitis and cancer. We established that mouse liver aldehyde dehydrogenase 1al
(Aldhlal) efficiently metabolizes lipid aldehydes and protects a liver-derived cell line
from the toxic effects of these aldehydes. Thus, mechanisms to induce the expression of
Aldhlal might be a useful rationale for preventing oxidative stress-induced pathologies.
We investigate whether well-known electrophiles, such as BHA or acrolein modulate the
expression of Aldhlal and elucidate the signaling pathway involved. Microarray
analyses were performed to examine whether acrolein or BHA up-regulate the expression
of genes encoding enzymes involved in antioxidant or electrophile detoxification in mice
liver. Mice were administered AIN76A (control) diet, diet containing 0.45% BHA or 5
mg/kg acrolein by gavage for 7 days. The expression of genes encoding several
electrophile detoxifying enzymes was specifically elevated, indicating a detoxification
response. The elevation of Aldhlal was noticeable, with a 2- to 3-fold increase by both
electrophiles. Quantitative real-time peR analysis also showed ;::::2.5-fold and ;::::3VI

fold induction of Aldhlal gene expression by BRA and acrolein, respectively. Livers
from BRA- and acrolein-treated mice also showed increased cytosolic Aldh activity
compared to control. Acrolein and tert-butylhydroquinone (the metabolized products of
BRA) are electrophiles that induce the expression of cytoprotective genes by direct
activation of nuclear factor-E2-related factor-2 (Nrf2), activator protein 1 (AP-l) and
nuclear factor kappa B (NF-KB) transcription factors or indirectly by activation of protein
kinases, such as MAPKs.
To decipher the signaling pathways involved in Aldhlal induction by
electrophiles, we analyzed the mRNA levels of Aldhlal in the liver ofNrf2+I+ and Nrf21-

mice on C57BL6 background exposed to BRA. Mice exposed to BRA showed ::::;2-fold

increase in mRNA levels of Aldhlal in both Nrf2+I+ and Nrf2-I-mice compared to
control, indicating that electrophile-induced expression might be independent ofNrf2.
However, the mRNA and protein levels of AP-l and the activity of c-Jun were
significantly increased by BRA. We hypothesized that electrophile-induced expression of
hepatic Aldhlal gene is mediated by activation of AP-l transcription factor. Transient
transfection experiments were conducted in RepG2 cells with Aldhlal 5'-flanking
luciferase reporter constructs. While co-transfection with Nrf2 expression plasmid alone
or in the presence of tBRQ had no effect, over-expression of c-JunlAP-l resulted in ::::;4fold induction in Aldhlal transcriptional activity. Moreover, c-Jun transactivates
Aldhlal promoter activity as a homodimer and not c-Junlc-fos heterodimer. We also
established by promoter deletion and mutagenesis analysis that two AP-l sites at position
-758 and -1069 relative to Aldhlal transcription start site are responsible for c-Junmediated transactivation of Aldhlal luciferase activity. EMSA analysis using biotin-

Vll

labeled probe and super shift with antibodies against c-Jun, c-fos and Nrf2 showed that cJun binds to the proximal AP-1 site at -758 but not at -1069. The recruitment of c-Jun to
this AP-1 site by BHA was confirmed by ChIP experiment, which showed ;:::;10-fold
enrichment to the proximal AP-1 site with c-Jun. These results indicate that electrophiles
promote the recruitment of c-JunlAP-1 to the Aldh1 a1 gene promoter, resulting in
increased transcription of Aldh1al.
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CHAPTER I
INTRODUCTION
Lipid and Environmental Aldehydes
Propene-2-al (acrolein) is a highly reactive

a,~-unsaturated

aldehyde ubiquitously

present as an environmental pollutant in cigarette smoke, vehicle exhaust emission,
drinking water and in effluents from industrial plants. It is produced by a variety of
natural and synthetic processes that include the incomplete combustion of organic
materials, such as fuels, plastic materials, wood, food, frying oils and tobacco (Stevens
and Maier, 2008). The amount of acrolein in a single puff of cigarette smoke is estimated
to range between 1.6 -22 f..lg/cigarette depending on the carbon filter of the cigarette
(Thweatt et aI., 2007). Acrolein is found at a concentration of 0.04 to 0.08 ppm in
ambient air (Beauchamp, Jr. et aI., 1985). However, acrolein levels can be as high as 90
ppm in cigarette smoke. Inhalation studies demonstrate that the lethal dose of acrolein in
mice is a 10 min exposure of 175 ppm (Beauchamp, Jr. et aI., 1985). The main
endogenous sources of acrolein are the biotransformation of allyl alcohol, allylamine,
spermine, spermidine and the widely used anticancer drug cyclophosphamide. Acrolein is
a major end product formed from the peroxidation of the ro-6 polyunsaturated fatty acids,
such as linoleic acid and arachidonic acid along with 4-hydroxynonenal (4-HNE),
crotonaldehyde, malondialdehyde (MDA), hexanal and trans-2-hexenal
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(Uchida K et al., 1998). Thus, humans are constantly exposed to acrolein and related
aldehydes in the environment. It is estimated that the maximum daily human
consumption of unsaturated aldehydes is
has been suggested to be

~

~5

mg/kg, while the total aldehyde consumption

7 mg/kg (Wang et al., 2008;Conklin et al., 2010).

Mechanism of cytotoxicity of a,~-unsaturated aldehydes
The

a,~-unsaturated

aldehydes, acrolein and HNE, are highly reactive

electrophiles and can undergo Michael addition reaction with nucleophilic groups on
proteins and DNA, forming stable covalent adducts (Esterbauer, 1993). These aldehydes
form adducts with proteins by reacting with cysteine sulfhydryl group, histidine
imidazole group and lysine £-amino group, resulting in alteration of several cellular
processes. Enzymes containing amino and sulfhydryl groups in their active site can be
inhibited by reactive aldehydes. For example, high levels of acrolein or HNE inhibit
aldehyde dehydrogenases, cytochrome P450, GST mu and pi and the glycolytic enzymes,
glyceraldehyde-3 phosphate and glucose-6 phosphate dehydrogenase (Berhane and
Mannervik, 1990;Kuo et al., 1997;Silva and O'Brien, 1989;Szweda et al., 1993;Uchida
and Stadtman, 1993). The conjugation of a,~-unsaturated aldehyde with reduced
glutathione (GSH) can induce oxidative stress by depleting cells of their natural
antioxidant, glutathione. HNE and acrolein are known to induce apoptotic and necrotic
cell death by activation of death signaling pathways involving caspases and the
mitochondrial permeability transition pore (mMTP) (Burcham and Fontaine, 2001).
Reactive aldehydes are implicated in the pathogenesis of a number of
inflammatory diseases in humans. The accumulation of reactive aldehydes in the liver
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can promote the influx of inflammatory cells by stimulating the production of the
pro inflammatory cytokines, TNFa, thereby amplifying inflammatory response
(Browning and Horton, 2004;Esterbauer et ai., 1991). In addition, reactive aldehydes are
also known to activate hepatic stellate cells leading to collagen deposition (Browning and
Horton, 2004), suggesting that lipid aldehydes are implicated in the transition from fatty
liver (steatosis) to steatohepatitis and other end stage liver diseases, such as liver fibrosis
and non-alcoholic steatohepatitis (NASH). HNE and acrolein have also been linked to the
pathogenesis of atherosclerosis (Uchida et ai., 1994). The low-density lipoprotein (LDL)
becomes more atherogenic when modified by acrolein and HNE triggering the uptake of
LDL by scavenger receptors located on vascular smooth muscle cells (Uchida et ai.,
1994;Uchida et ai., 1998;Uchida, 2000). Thus, high levels of 4HNE- and acroleinmodified proteins have been detected in atherosclerotic lesions (Uchida et ai.,
1994;Uchida et ai., 1998). Cytotoxic aldehydes playa major role in the progression of
myocardial ischemia reperfusion injury by activation of the mMTP (Eaton et ai., 1999).
The opening of the mMTP is considered a primary event in necrotic cell death in
myocardial ischemia-reperfusion injury. Thus, a small-molecule activator of ALDH2
(Alda-1), when administered to rats before an ischemic event, reduced infarct size by
60%, most likely through its inhibitory effect on the formation of protein adducts by
electrophilic aldehydes (Chen et ai., 2008). Therefore, the metabolism of these toxic
compounds to less reactive and excretable compounds is of great importance in
ameliorating lipid aldehydes induced human diseases.

The Aldehyde Dehydrogenase (ALDH) genes
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Although the mechanism of reactive aldehydes-induced cytoxicity has been
extensively studied, little is known about how cells respond to toxic insults by

a,~

unsaturated aldehydes. Cells have developed elaborate methods to resist cytotoxic
aldehydes by the presence of cytoprotective genes encoding enzymes involved in
aldehyde metabolism and detoxification. Multiple pathways are involved in the
metabolism of acrolein and HNE including oxidation to carboxylic acid, reduction to an
alcohol and the conjugation to GSH. The enzymes involved include glutathione Stransferase (GST), ALDH, aldo-keto reductases (AKR), alcohol dehydrogenase (ADH)
and cytochromes P450 (CYP) (Amunom et aI., 2007;Marchitti et aI., 2008;Srivastava et
aI., 2001). The importance of these enzymes in acrolein and HNE detoxification is cell
type- and species-dependent. Intravenous administration of acrolein into rats
demonstrates that AKRs also playa major role in the metabolism of acrolein especially in
the heart (Stevens and Maier, 2008). However, in vitro studies ofHNE metabolism
performed with isolated hepatocytes and perfused mice livers suggest that both Aldhs and
GST are the main enzymes involved in lipid aldehyde metabolism in hepatic tissues
(Hartley et aI., 1995).
ALDHs gene superfamily encodes enzymes that catalyze the irreversible
oxidation of endogenous and exogenous aldehydes to their corresponding non-toxic
carboxylic acids using either NAD+ or NADP+ as cofactor. These enzymes play critical
roles in the cellular protection against oxidative damage induced by cytotoxic aldehydes
by metabolizing these aldehydes to a form that is easily excreted. The active ALDH
enzyme is composed of subunits that form either a homodimer or homotetramer protein.
Each subunit is characterized by a Rossmann fold and contains an NAD(P)-binding
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domain, a catalytic domain and an oligomerization domain (Marchitti et aI., 2008). A
funnel-shaped opening at the interface of these domains leads to a putative catalytic
pocket and is essential for substrate specificity. The ALDH Rossmann fold contains the
structural motif, (GxxxxG; x represent any protein residue) which is necessary for
cofactor binding. An invariant cysteine is found at the catalytic site of all ALDHs and is
essential for the formation of the thiohemiacetal intermediate (Marchitti et aI., 2008).
Members of the ALDH gene superfamily are composed of 555 genes in both
eukaryotes and prokaryotes. To date, 172 ALDH genes have been identified in
eukaryotes (Sophos and Vasiliou, 2003) with 19 functional ALDH genes in the human
genome (Alnouti and Klaassen, 2008;Ellis, 2007;Marchitti et aI., 2008). Three isozymes,
the cytosolic ALDH1A1 and ALDH3A1, and the mitochondrial ALDH2 are implicated
in the detoxification of lipid-derived aldehydes. However, the role of Aldh isozymes in
cellular protection against cytotoxic aldehydes especially in mice liver is still not
completely understood.
ALDH2 is a homo- or heterotetramer highly expressed in the liver and
extrahepatic tissues. The human ALDH2 is encoded in the nucleus and imported to the
mitochondrial matrix with the help of a 17 amino acid N-terminal mitochondrial
localization sequence. ALDH2 enzyme plays a major role in the alcohol metabolism
pathway based on its low Km «5 IlM) for acetaldehyde oxidation (Klyosov et aI., 1996).
Asian individuals carrying a catalytically inactive form of the enzyme with a point
mutation in ALDH2 (ALDH2*2) experience the facial flushing after alcohol ingestion,
caused by elevated blood acetaldehyde (Goedde et aI., 1992). Emerging evidence
indicates that ALDH2 plays a crucial role in cytoprotection against myocardial ischemia-
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reperfusion injury probably by detoxifying reactive aldehydes such as HNE (Chen et aI.,
2008).
ALDH3Al is a homodimer that oxidizes medium chain aliphatic and aromatic
aldehydes, and utilizes either NAD+ or NADP+ as cofactor. Aldh3al is poorly expressed
in normal murine liver but is constitively expressed in the cornea where it protects the
eye from UV -induced oxidative damage by scavenging hydroxyl radicals and
detoxification of lipid peroxidation-derived aldehydes, such as HNE (Alnouti and
Klaassen, 2008;Lassen et aI., 2007). ALDH3Al efficiently metabolizes cytotoxic lipid
aldehydes and protects cells against HNE-induced apoptosis (Townsend et aI., 2001).
ALDH3Al plays a major role in the metabolism of the anticancer drug
cyclophosphamide and increased expression of ALDH3Al with ALDHIAI is
responsible for the resistant phenotype exhibited by most cells to cyclophosphamide
toxicity (Marchitti et aI., 2008).
The cytosolic ALDHIAI enzyme is a homotetramer protein highly expressed in
the liver, lung and retina. ALDHIAI plays an important role in retinoic acid (RA)
biosynthesis by efficiently catalyzing the oxidation of both all-trans- and 9-cis-retinal
(Marchitti et aI., 2008;Vasiliou et aI., 2004). Thus, ALDHIAI regulates normal growth,
differentiation and development of adult epithelia by synthesizing RA, a ligand for the
nuclear RA receptor (RAR) and retinoid X receptor (RXR). Aldhlal gene is expressed at
higher levels in human hematopoietic stem cells (HSCs), and is critical for stem cell
differentiation and function (Chute et aI., 2006). The human ALDHIAI utilizes either
NAD+ or NADP+ as cofactor, but prefers NAD+ over NADP+ (Xiao et aI., 2009).
Previous studies revealed that the human ALDHIAI provides only moderate protection
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against trans-2-nonenal and not against other lipid aldehydes, such as HNE, acrolein and
trans-2-hexenal (Townsend et aI., 2001). However, there is compelling evidence to

suggest that ALDHIAI plays a prominent role in the cellular defense against oxidative
damage induced by cytotoxic aldehydes. Studies with Aldhlal-I - mice indicate that
Aldhlal protects the eye lens and cornea from cataract formation due to ageing- or UV
radiation-induced oxidative stress by detoxifying cytotoxic lipid aldehydes (Choudhary et
aI., 2005;Lassen et aI., 2007). The human lens ALDHIAI efficiently oxidizes lipidderived aldehydes, including HNE (Km 4.8 11M), trans-2-heptenal (Km 177 11M) and
MDA (Km 3.5 11M) (Marchitti et aI., 2008;Xiao et aI., 2009).
In addition to its role in detoxification of lipid aldehydes, Aldhlal plays an
important role in drug and xenobiotic metabolism. Over-expression of Aldhlal causes
resistance to the anticancer drug, cyclophosphamide (CP) by detoxifying its major active
aldehyde metabolite, acrolein (Moreb et aI., 2007). Aldhlal is one of the major enzymes
involved in the metabolism of toxic ethanol metabolite, acetaldehyde (Km 50-180 11M)
(Browning and Horton, 2004;Marchitti et aI., 2008). ALDHIAI also possesses a pnitrophenyl acetate esterase activity and is involved in the bioactivation of the antianginal
drug, nitroglycerin (Beretta et aI., 2008). Furthermore, recent studies indicate that
ALDHIAI is a major enzyme responsible for detoxification of3-deoxyglucosone, which
is produced by the process of glycoxidation, and 3-deoxyglucosone is implicated in the
pathogenesis of diabetes (Collard et aI., 2007). We hypothesized that Aldhlal is the
major enzyme involved in acrolein and other lipid aldehyde detoxification in mouse liver.
Thus, an understanding of the molecular mechanism regulating Aldhl al gene expression
is of importance in potentially attenuating the toxic action of carbonyl compounds.
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The Aldehyde dehydrogenase 1a1 gene regulation

Even though Aldhlal is constitutively expressed in various tissues especially the
liver, the expression of Aldhlal gene is known to be altered by a wide variety of
endogenous and exogenous stimuli. The levels of Aldhlal mRNA were markedly lower
in mice with elevated levels of hepatic RA, suggesting that elevated hepatic RA downregulates Aldhlal expression in a feedback pathway to control RA biosynthesis
(Andreola et aI., 1997). Aldhlal is a major enzyme involved in RA biosynthesis.
Transient transfection studies revealed that RARa and the CCAAT/enhancer-binding
protein

~ (C/EBP~)

transactivate the Aldhl gene. The activation of Aldhlal gene

expression by RAR was further supported by the fact the RXRa-l - mice display decreased
liver Aldhlal levels (Gyamfi et aI., 2006). The molecular mechanism ofRA-induced
down-regulation of Aldhlal was attributed to RA-mediated decrease in the mRNA
expression of C/EBP~ (Elizondo et aI., 2000;Elizondo et aI., 2009).
Aldhlal was previously shown to be induced by phenobarbital (PB) treatment in
rat (Pappas et aI., 2001). Alnouti and Klaassen also reported induction of Aldhlal gene
in mouse liver by constitutive androstane receptor (CAR) activators, presumably
operating through a CAR binding site in the 5 '-flanking region of Aldhlal gene (Alnouti
and Klaassen, 2008). The 5' -flanking region of the mouse Aldh 1al gene was previously
characterized and is highly conserved to that of the rat and human ALDHI (Hsu et aI.,
1999;Hsu et aI., 2000). It contains putative cis-acting regulatory elements such as GAT A,
AP-l, Nrf2, SP-l NF-K B, AhR-Arnt, CAR and Stat5 binding sites. There is also the
presence of an Oct 1 and a CCAA T binding sites which are highly conserved in the rat
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and human gene, and are essential for basal promoter activity (Guimond et aI., 2002;Hsu
et aI., 1999).
Aldh1a1 expression is reported to be enhanced by chemicals which are known to
activate redox-sensitive transcription factors, such as Nuclear Factor-E2-related factor-2
(Nrf2). For example, oxidative and electrophilic stress were shown to modulate the
expression of Aldh1a1 and other cytoprotective genes by activation ofNrf2 (Hu et aI.,
2006;Lamle et aI., 2008;Leonard et aI., 2006;Reisman et aI., 2009;Thimmulappa et aI.,
2002). We also showed by micro array profiling in mice liver that Aldh1a1 gene
expression was induced by electrophiles, such as BHA and acrolein (Amunom, Makia
and Prough, unpublished report). However, the signaling pathway involved in
electrophile-induced expression of Aldh1a1 gene is not completely understood.
Electrophiles and oxidants modulate the expression of cytoprotective genes by activation
of redox-sensitive transcription factors, such as Nrf2, AP-1 and NF-KB.

The Nuclear Factor-E2-related factor-2 (Nrf2) transcription factor
The transcription factor Nrf2 belongs to the cap-n-collar (CNC) family of basic
leucine zipper (bZIP) proteins. In addition to oxidants, Nrf2 is activated by chemical
compounds that undergo redox cycling or be metabolized to reactive or electrophilic
intermediate (Rushmore et aI., 1990;Rushmore and Pickett, 1991). A wide variety of
natural and synthetic compounds are known activators ofNrf2, such as BHA and its
metabolite tert-butylhydroquinone (t-BHQ), sulforaphane (SFN), 1,2 dithiole-3-thione
(D3T), phenethylisothiocyanate (PEITC) and reactive aldehydes. The mechanism of
activation ofNrf2 by aldehydes and other electrophiles is not completely understood.

9

However, the activation ofNrf2 by oxidative stress and electrophiles is proposed to occur
by one of two mechanisms (Nguyen et aI., 2003;Nguyen et aI., 2004;Nguyen et aI.,
2009). In the absence of oxidative and electrophilic stress, Nrf2 is localized in the
cytoplasm in a complex with Kelch-like ECH-associated protein 1 (Keap-l) that
facilitates the degradation ofNrf2 via the proteosomal system. Thus, under basal
conditions the levels ofNrf2 is kept relatively low. Oxidative and electrophilic stress
causes modification of cysteine residues within the hinge region of Keap-l, disrupting its
association with Nrf2 and leading to nuclear translocation ofNrf2.
Electrophiles, such as reactive aldehydes and BHA can also activate Nrf2
indirectly by activation of protein kinase signaling pathways (Huang et aI., 2002;Huang
et aI., 2000). The depletion of GSH by reactive aldehydes and other electrophiles causes
oxidative stress that activates stress-signaling pathways involving kinases. Electrophiles
have been shown to directly activate Rafl (a MAPK kinase kinase), which then
phosphorylates and activates MEK (a MAPK kinase) (Yu et aI., 1997). The involvement
of mitogen-activated protein kinase (MAPK), such as p38, c-Jun N-terminal kinase
(JNK) and extracellular signal-regulated kinases 1 and 2 (ERKl/2) in the activation of
Nrf2 is well established (Wu et aI., 2006;Yu et aI., 1997;Yuan et aI., 2006). Furthermore,
acrolein-mediated activation ofNrf2 was dependent on the phosphatidylinositol-3-kinase
(PI-3K) and protein kinase C (PKC) signal pathways (Zhang and Forman, 2008). The
phosphorylation ofNrf2 at Ser 40 by PKC has been demonstrated to activate Nrf2
(Huang et aI., 2002;Huang et aI., 2000).
The activated Nrf2 heterodimerizes with small Maf (MafF, MafG and MafK)
proteins and coordinates expression of antioxidant and electrophile detoxification genes
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by binding to the antioxidant/electrophile response element (ARE/EpRE) commonly
found in the promoter or enhancer region of these genes (Rushmore et aI., 1991). Gene
expression profiling in the liver of Nrj2+I+ and Nrj2-I- mice exposed to prooxidants
revealed that Nrf2 regulates hundreds of genes, including several antioxidant and
electrophile detoxification enzymes (Hu et aI., 2006). The most notable of these genes are
the glutathione S-transferases (GSTA2, GSTP, Gsta1 and Gstml), y-glutamyl synthetase
(y-GCS), NADPH: quinone oxidoreductases (NQO-1), heme oxygenase (HO-l),
glutathione peroxidases (GPx) and glutathione reductases (GR). We and others have
shown that the Nrf2 activators, BHA and acrolein, increased mRNA expression of

Aldhl al. The signaling pathways involved in the transcriptional regulation of Aldhl al
gene by BHA and acrolein have not been previously studied. Moreover, it is not yet
known whether Aldhl al is a direct target ofNrf2. However, aside from Nrf2, BHA and
reactive aldehydes are also known to induce the transcriptional activity of the AP-l and
NF-KB transcription factors (Choi and Moore, 1993;Iles and Liu, 2005).

The Activator Protein 1 (AP-l) transcription factor
The AP-l transcription factors are basic leucine zipper (bZIP) proteins that include
members oftheJos (c-fos, Fos-B, Fra-l and Fra-2),jun (c-lun, lun B and lUll D) and the
activating transcription factors (ATFI-5 and B-ATF). Members ofthejun family are
known to regulate gene expression as either homodimers or as heterodimers with
members oftheJos family. The dimeric AP-1 binds to cis-acting 12-0tetradecanoylphorbol 13-acetate (TPA)-responsive element (TRE) in the promoter of
target genes (Eferl and Wagner, 2003) (Figure 1) CEferl and Wagner, 2003). The TRE
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was originally described in the human collagenase gene promoter and has the sequence,
5' -ATGAC/GTCA-3'. C-Jun is also known to form heterodimer protein complexes with
Nrf2 and ATF2. The heterodimers of c-Jun with ATF-2 and Nrf2 are known to bind to
the cyclic AMP response element (CRE) and ARE, respectively (Figure 1). The c-Jun
protein has a b-ZIP DNA-binding domain and a transactivation domain containing
phosphorylation sites for stress-activated protein kinases (SAPKs) such as JNK, p38 and
ERK1I2. In response to oxidative and electrophilic stress, the SAPKs phosphorylate cJun and enhance its trans activating capacity. In addition, reactive aldehydes can enhance
the transcriptional activity of AP-1 by induction of AP-1 gene expression (Pugazhenthi et
ai., 2006;Ranganna et ai., 2002;Tirumalai et ai., 2002;Wu et ai., 2006;Zhang and Forman,
2008).
AP-1 proteins have been implicated in several signal transduction pathways
associated with cellular growth, differentiation and cellular stress (Eferl and Wagner,
2003). AP-1 can either promote or antagonize cell survival in a tissue- and stressdependent manner. The mechanism that accounts for the dual role of AP-1 in apoptosis
and survival signaling has not been established. Previous studies showed that c-Jun acts
downstream of JNK to induce apoptosis in TNFa-stimulated thymocytes (Hasselblatt et
ai., 2007). However, c-jun null mice die at midgestation and display increased apoptosis
of fetal liver cells (Eferl and Wagner, 2003). A more recent study indicates that oxidative
stress-mediated induction of c-JunlAP-1 promotes hepatocyte survival during acute
hepatitis by transcriptional regulation of inducible nitric oxide synthase (Nos 2) gene
(Hasselblatt et ai., 2007). These results indicate that c-Jun has hepatoprotective functions
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Figure 1. The basic leucine zipper (bZIP) family proteins and their binding partners. The
jun family members can form either homodimer or heterodimers with members of the fos
family. The dimeric AP-I binds to cis-acting 12-0- tetradecanoylphorbol I3-acetate
(TP A)-responsive elements (TRE) in the promoter of target genes (Eferl and Wagner,
2003). c-Jun also form heterodimers with ATF-2 and Nrf2 which binds to the cyclic
AMP response element (eRE) and antioxidant response element (ARE), respectively.
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especially against oxidative stress (Eferl and Wagner, 2003;Hasselblatt et aI.,
2007;Marden et aI., 2008;Tsuji, 200S). We propose that increased transcriptional
activation of the aldehyde-metabolizing gene, Aldhlal, by reactive aldehydes is mediated
by activation of c-JunJAP-l proteins.

The nuclear factor kappa B (NF-KB)

Nuclear Factor kappa B (NF-KB) proteins are redox-sensitive transcription
factors, which play key roles in immune and inflammatory responses. There are five NFKB proteins in mammals: RelA (p6S), RelB (P68), c-Rel (p7S), pSO and pS2 (Karin,
1999). They modulate gene expression by forming a variety ofheterodimers and
homodimers with each other. In most tissues, the predominant NF-KB dimer is a pSO/p6S
heterodimer. NF-KB proteins are also known to modulate gene expression by forming
active heterodimers with AP-l proteins (Rahmani et aI., 2001). NF-KB proteins are held
in an inactive state in the cytoplasm by inhibitory proteins known as IKB. Following
exposure to oxidative stimuli and electrophiles, IKB undergoes phosphorylation,
ubiquitination and subsequent degradation of IKB (Karin, 1999). The degradation of IKB
leads to the release of the pSO/p6S complexes, resulting in nuclear translocation and
transcriptional activation of specific target genes. These target genes are involved in
inflammatory responses to infection and stess.
We hypothesize that mouse liver displays a protective response to toxic aldehydes
by enhanced metabolic inactivation of these toxic species, mediated by induction of
Aldhlal enzymes. Moreover, electrophile-induced expression of Aldhlal gene is
mediated by c-JunJAP-1.The goal of these studies is two-fold. 1. To examine whether
14

lipid aldehydes and their GSH conjugates are substrates for Aldhlal. 2. To decipher the
signaling pathways involved in electrophile-mediated induction of Aldhlal gene
expression in mouse liver.
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CHAPTER II
MURINE HEPATIC ALDEHYDE DEHYDROGENASE IAI (Aldhlal) IS A
MAJOR CONTRIBUTOR TO OXIDATION OF ALDEHYDES FORMED
BY LIPID PEROXIDATION
INTRODUCTION
The liver, as the major site for metabolism and biotransformation of drugs and
foreign compounds, is constantly exposed to reactive oxygen species (ROS), resulting in
oxidative stress. During oxidative stress, these ROS, which include hydrogen peroxide
(H 20 2), superoxide radicals (Oi-) and hydroxyl radicals (OH.), can covalently modify
proteins, lipids and DNA. The peroxidation of polyunsaturated fatty acids in membrane
lipid by ROS produces unstable lipid hydroperoxides that decompose into aldehydes such
as malondialdehyde (MDA), hexanal, trans-2-hexenal, propen-2 al (acrolein) and 4hydroxy-2-nonenal (HNE) (Esterbauer et aI., 1991 ;Esterbauer, 1993). Among these
aldehydes, HNE and acrolein are highly electrophilic

a,~-unsaturated

aldehyde that can

undergo Schiff base and Michael addition reactions with nucleophilic groups on proteins
and DNA (Esterbauer, 1993). There is increasing evidence that the pathophysiological
effects of ROS in cells is mediated by these cytotoxic aldehydes because they are more
chemically stable than ROS and thus, can diffuse to distant sites from where they are
formed (Ellis, 2007;Uchida et aI., 1994).
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In addition, humans are exposed to these aldehydes as environmental pollutants
and by endogenous processes generating reactive aldehydes in the liver. For example,
chronic alcohol consumption, high fat diet or exposure to foreign compounds such as
carbon tetrachloride (CCI 4), allyl alcohol and the widely used anticancer drug,
cyclophosphamide, markedly elevate the intracellular concentrations of cytotoxic
aldehydes (Dwivedi et al., 2006;Nanji et al., 1994;Sampey et al., 2007;Stevens and
Maier, 2008). Reactive

a,~-unsaturated

aldehydes, such as acrolein and crotonaldehyde

are also present in cigarette smoke, vehicle exhaust emission, overheated foods and oil,
drinking water and in effluents from industrial plants (Feron et al., 1991;Stevens and
Maier, 2008). The maximum daily human consumption of unsaturated aldehydes is
estimated at ~5 mg/kg whereas the total aldehyde (saturated and unsaturated)
consumption is estimated at ~7 mg/kg (Wang et al., 2008;Conklin et al., 2010).
The levels of reactive lipid aldehydes are elevated in various oxidative stressmediated diseases, including steatohepatitis (Chen et al., 1997), atherosclerosis (Uchida
et al., 1994), Alzheimer's disease (Sayre et al., 1997), cataractogenesis (Srivastata et al.,
1996), diabetes (Toyokuni et aI., 2000) and cancer (Hammer et al., 1997). In fact,
accumulation of reactive aldehydes is associated with the pathogenesis of these diseases.
The toxicity of a,~-unsaturated aldehyde lies in their ability to form Michael adducts with
thiol and amino groups of proteins resulting in alteration of several cellular processes. For
example, enzymes such as glyceraldehyde-3-phosphate, glucose-6-phosphate
dehydrogenases and cytochrome c oxidase containing lysine and cysteine residues in
their active sites are readily inactivated by conjugation with these reactive aldehydes
(Chen et al., 2001;Szweda et al., 1993;Uchida and Stadtman, 1993). In addition,
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a,~-

unsaturated aldehydes can induce oxidative stress in cells by depleting cellular reduced
glutathione, thereby altering signal transduction pathways in cells. At low
concentrations, acrolein is known to trigger apoptotic cell death by mechanisms that
involve activation of mitochondrial death pathways and caspases (Burcham and Fontaine,
2001 ;Stevens and Maier, 2008;Tanel and Averill-Bates, 2007). Caspases, particularly
caspase 3, which can cleave substrates, such as poly(ADP-ribose) polymerase (PARP),
actin and laminin, are widely used as markers for apoptosis in different cell types.
However, at high concentrations acrolein causes necrotic cell death. This phenomenon
has also been observed with HNE (Cheng et aI., 2001;Thomberry and Lazebnik,
1998;Zhang et aI., 2010).
Despite their toxicity, many cytotoxic lipid-derived aldehydes can be successfully
metabolized to less toxic compounds by the action of oxidative, reductive and
conjugative enzymes. These enzymes include glutathione S-transferases (GST), aldehyde
dehydrogenases (ALDH), aldo-keto reductases (AKR), alcohol dehydrogenases (ADH)
and cytochrome P450 (CYP) (Amunom et aI., 2007;Conklin et aI., 2007;Marchitti et aI.,
2008;Srivastava et aI., 1998;Srivastava et aI., 2001). The relative importance of these
enzymes in reactive aldehyde metabolism is cell type- and species-dependent. It is now
known that the conjugation of acrolein with glutathione may not be a true detoxification
process because acrolein-glutathione conjugates can undergo renal processing to form
reactive species (Ramu et aI., 1995). In addition, the conjugation process is compromised
when GSH concentrations are depleted during oxidative stress. ALDH oxidizes a range
of toxic aldehydes to their corresponding non-toxic carboxylic acids using either NAD+
or NADP+ as cofactors. ALDHs playa critical role in the cellular protection against these
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toxic species. There are 19 ALDH genes in the human genome (Marchitti et aI., 2008).
To date, three isozymes, the cytosolic ALDHIAI and ALDH3Al, and the mitochondrial
ALDH2 are suggested to be the main lipid aldehyde-oxidizing enzymes expressed in the
mouse liver.
The role of these enzymes in the cellular defense against oxidative damage
induced by cytotoxic aldehydes is controversial. Previous studies by Townsend et al
revealed that ALDHIAI over-expression provides only moderate protection against
trans-2-nonenal and not against other lipid aldehydes (Townsend et aI., 2001). However,

ALDH3Al could protect RAW 264.7 murine macrophage cell line against HNE-induced
apoptosis, consistent with the prevention ofHNE-protein adduct formation (Townsend et
aI., 2001). Mouse Aldh3al is poorly expressed in normal liver and highly expressed in
cancerous cells (Alnouti and Klaassen, 2008). It is also abundantly expressed in the
cornea and protects the cornea against cytotoxic lipid peroxidation-derived aldehydes
(Lassen et aI., 2007). However, recent experiments with Aldhlal-I - mice indicate that
Aldhlal also protects the eye from cataract formation induced by oxidative stress by
detoxifying cytotoxic lipid aldehydes (Choudhary et aI., 2003;Choudhary et aI., 2005).
Moreover, the human lens ALDH1A1 efficiently oxidizes lipid-derived aldehydes,
including HNE (Km 4.8 J-lM), trans-2-heptenal (Km 177 J-lM) and MDA (Km 3.5 J-lM)
(Xiao et aI., 2009). In addition, over-expression of ALDHI in neuroblastoma cells
reduces both production ofprotein-HNE adducts and activation of caspase-3 (Zhang et
aI., 2010). Aldh1a1 is known to decrease the effectiveness ofthe anticancer drugs
cyclophosphamide by detoxifying its major active metabolites acrolein (Moreb et aI.,
2007). These results indicate that Aldh1a1 has the potential to protect against aldehydes
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produced as a result of lipid peroxidation. However, it is unknown whether Aldhlal can
protect against acrolein-induced toxicity in mouse liver. We hypothesized that Aldhlal is
the major enzyme involved in acrolein and other lipid-derived aldehyde metabolism and
detoxification in mouse liver.
Although considerable characterization of the rat ALDHs in cytosol and
mitochondria has been published, the relative contribution of different Aldh isozymes in
metabolism and detoxification of reactive aldehydes in mouse liver is unknown.
Moreover, the kinetic properties of murine Aldh orthologs in oxidation of reactive lipid
aldehydes especially acrolein, have not been biochemically measured. Mouse is a more
common laboratory model for research in medicine because of the availability of
transgenic and until recently, the only source for gene-targeted and knockout mice. In the
present study, we examined the role of murine hepatic Aldh isozymes in metabolism and
detoxification of lipid-derived aldehydes, including acrolein and HNE, by enzyme kinetic
and gene expression studies. In this chapter, we show by substrate preferences, gene
expression patterns and in vitro knockdown experiments in Hepa-lclc7 that murine
Aldhlal is the major cytosolic Aldh in mouse liver involved in cellular defense against
reactive aldehydes-induced toxicity.

MATERIALS AND METHODS

Chemicals and Reagents
Propionaldehyde, benzaldehyde, trans-2-hexenal, acetaldehyde, dithiothreitol
(DTT), 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), isopropyl
~-D-l-thiogalactopyranoside

(IPTG), N-ethylmaleimide (NEM), propen-2-al (acrolein)
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and malonaldehyde bis-( dimethyl acetal, MDA) were purchased from Sigma-Aldrich
Company, Inc. (St Louis, MO). 4-hydroxy-2-nonenal (HNE) was obtained from Cayman
Chemical Co (Ann Arbor, MI). Oxidized ~-NAD+ and ~-NADP+ were purchased from
Codexis (Redwood City, CA). Anti-glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) antibody (clone 6C5, MAB374) was purchased from Millipore (Temecula,
CA). Rabbit polyclonal antibody against caspase 3 (H-277; sc-7148) was purchased from
Santa Cruz Biotechnology, Inc (Santa Cruz, CA). Cleaved caspase 3 (AspI75)
antibodies (#9661), and cytochrome c treated and untreated Jurkat cell extracts (#9663)
were from Cell Signaling Technology (Danvers, MA). ALDHI antibody against purified
rat ALDHI was produced in rabbits (Tweedie et aI., 1991). Rabbit polyclonal antibody
against acrolein-protein adducts was provided by Aruni Bhatnagar, Department of
Medicine/Cardiovascular Medicine, University of Louisville. Stealth™ RNAi was
synthesized by Invitrogen (Carlsbad, CA).

Cloning, Expression and Purification of Recombinant Aldhlal, Aldh2 and Aldh3al
The pCMV6-Aldhlal plasmid (MC202273) and pCMV6-Aldh2 (MR208315)
containing the full length of mouse Aldhlal cDNA (NM_013467) and Myc-DDK-tagged
mouse Aldh2 (NM_009656.2) Open Reading Frame (ORF), respectively, were purchased
from OriGene (Rockville, MD). The ORF of Aldhlal was amplified by PCR using the
following primers (forward: 5'-CATATGTCTTCGCCTGCACAACCTGCA-3'; reverse:
5'-GGTACCGGAGTTCTTCTGAGATATCTTCA-3'). On the other hand, the ORF for
Aldh2 was obtained using the following primers (forward: 5'CATATGTCCGCCGCCGCCACCAGCGC-3'; reverse: 5'-
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GGTACCCGAGTTCTTCTGTGGCACTTTGA-3 '). The forward primer for
amplification of Aldh2 was designed to remove the mitochondrial signal sequence by
PCR. Both forward primers contain an Nde1 site for cloning into the start codon (ATG)
ofpET30b vector (Novagen, Inc., Madison, WI) to ensure correct initiation of translation
in E coli. The reverse primer was designed to contain a Kpn1 site with deletion of the
stop codon (TAA) to express a full length Aldh1a1 with a C-terminal his-tag. The 1.5 kb
PCR product was then cloned into pCR2.1 vector using a TA cloning vector kit
(Invitrogen, Carlsbad, CA). The sequence of the mouse Aldh1a1 and Aldh2 ORF was
confirmed by sequence analysis at the University of Louisville, Center for Genetics and
Molecular Medicine Nucleic Acid Core Facility. The PCR product was then digested
with Nde1 and Kpn1, and subcloned into the pET30b expression plasmid (Novagen, Inc.,
Madison, WI). To generate the full length of mouse Aldh3a1 cDNA (NM_007436), total
RNA was isolated from mouse primary hepatocytes treated with 50 ""M 1,2benzanthracene (BA) for 24 h. Total RNA was reverse transcribed to cDNA with OligodT primers using Advantage RT-for-PCR kit (Clontech, BD Bioscience, Palo Alto, CA).
The ORF of Aldh3a1 was generated by PCR using as forward primer, 5'GGTACCAGCAATATCAGTAGCATCG-3' and as reverse primer, 5'CTCGAGTGAAGTAGCCCTCTCAATGC-3' .
The sequence of the mouse Aldh3a1 ORF PCR product was confirmed by
sequence analysis. The 1.5 kb PCR product was ligated into pCR2.1 vector and
subsequently digested with Kpn1 and Xho1, and subcloned into pET30a (Novagen)
expression vector allowing synthesis of a full-length Aldh3a1 with an N-terminal his-tag.
One Shot® BL21 (DE3)pLysS competent E. coli (Invitrogen, Carlsbad, CA) were
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subsequently transformed with pET30b-Aldh1a1 or pET30a-Aldh3a1 plasmid and were
grown until the OD 6o o ~ 0.6. The recombinant protein expression was induced by
addition of 0.5 mM IPTG overnight. Cells were lysed with Bugbuster® Protein
extraction reagent (Novagen, Inc., Madison, WI) containing 2 mM DTT and 10%
glycerol, and purified using nickel-nitrilotriacetic acid (Ni-NTA) column (Qiagen,
Valencia, CA). Proteins were eluted with 400 mM imidazole and concentration was
determined by Pierce® BCA Protein Assay (Pierce, Rockford, IL). The purity of the
recombinant protein was determined by SDS-PAGE electrophoresis stained with
coomassie blue (Figure 2). We noted a single protein band at ~ 55 and 50 KDa in the
eluate fractions of the pET30b-Aldh1a1 and pET30-Aldh3a1 transformed E. coli,
respectively (Figure 2). To further confirm the identity of Aldh1a1, extracts from
BL21 (DE3)pLysS cells transformed with pET30b-Aldh1a1, and purified rat ALDH1
(Tweedie et aI., 1991) were resolved on SDS-PAGE gel, transferred onto nitrocellulose
membrane and probed with antibody against purified rat ALDH1Al.

Aldehyde Dehydrogenase Enzymatic Assay
The enzymatic activities of Aldhs were measured spectrophotometric ally using
recombinant his-tag proteins by monitoring the reduction ofNAD+ or NADP+ at 340 nm
as previously described by Lindahl and Petersen (Lindahl and Petersen, 1991) using the
molar absorptivity value of 6,220 M-1cm- 1. Enzyme activity was assayed at 25°C in 50
mM sodium phosphate buffer (pH 7.4), containing 1 mM EDTA and 0.01 % BME with
either 1 mM NAD+ or NADP+ as cofactor. The reaction was initiated by addition of
varying concentrations of aldehyde substrate into a 1 ml cuvette. The kinetic constants
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Figure 2. SDS-PAGE analyses of purified recombinant mouse Aldh. (AJ Cell extracts
(CE) from pET30a, pET30b-Aldh1a1 or pET30a-Aldh3a1 transformed BL21 (DE3)pLysS

E coli and eluate fractions purified using Ni-NTA resin were resolved on 4-12% SDSPAGE and stained with coomassie blue. Lane 1: Prestained Marker; Lane 2: CE from
pET30a transformed E coli; Lane 3: eluate fractions from pET30a vector transformed E

coli; Lane 4: Lysates from pET30b-Aldh1a1 transformed E coli; Lane 5: eluate fractions
from pET30b-Aldh1a1 transformed E coli; Lane 6: CE from pET30a-Aldh3a1
transformed E coli; Lane 7: eluate fractions from pET30b-Aldh1a1 transformed E coli.
(B) Western blot analysis of recombinant Aldh1 a1. Extracts from BL21 (DE3)pLysS
transformed with pET30b-Aldh1a1 and purified rat liver ALDH1A1 immunoblotted with
antibody against rat ALDHl. Due to the presence of his-tag the migration of the
recombinant mouse Aldh1a1 is slower than that of purified rat Aldh1. Lane 1: Eluate
fractions from BL21(DE3)pLysS transformed with pET30b-Aldh1a1 plasmid; Lane 2:
ALDHIA1 purified from rat liver.
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(Km, V max and Vmax/Km) of recombinant mouse Aldh1a1 and Aldh3a1 for oxidative
metabolism of various aldehydes were examined. All reactions were performed
in triplicate. Malondialdehyde (MDA) was prepared by acid hydrolysis of malonaldehyde
bis-(dimethyl acetal) (Sigma-Aldrich Co, St. Louis, MO) by adding 17 !lL to 900 !lL of
0.1 N HCl and incubating the solution at room temperature for 2 h (vortexing every 30
min). The pH was neutralized with 1 N NaOH prior to use to achieve a 100 mM
concentration. The cofactor preference of recombinant mouse ALDH was measured
using varying concentrations of either NAD+ or NADP+. The Km of Aldh1a1 for NAD+
and NADP+ was defined using 1 mM propionaldehyde while the cofactor preference of
Aldh3al was assessed by measuring its Km for either NAD+ or NADP+ using 2.5 mM
benzaldehyde as substrate.

Stealth™ siRNA knockdown of mouse Aldhlal
Stealth™ RNA oligonucleotides are 25 bp double-stranded RNA oligonucleotides
and were designed using BLOCK-iTTM RNAi Designer (Invitrogen, Carlsbad, CA). The
Stealth siRNA designed to target mouse Aldh1a1 (NM_013467) was synthesized by
Invitrogen (sense strand, 5'-UAAAGAUGCCAGGUGAAGAGCCGUG-3'; antisense
strand, 5'-CACGGCUCUUCACCUGGCAUCUUUA-3'). The sequences of the Stealth
siRNA control are: sense strand, 5'-CACUCUCCUCAUCGGACCUUGGUUA-3';
antisense strand, 5' -UAACCAAGGUCCGAUGAGGAGAGUG-3 '). Before transfection,
mouse hepatoma (Hepa-1clc7) cells (American Type Culture Collection, Rockville, MD)
were maintained in Dulbellco Modified Eagle's Media (DMEM) supplemented with 10%
fetal bovine serum and 1% Antibiotic-Antimycotic (Invitrogen; Carlsbad CA). Cells were
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transfected with either 150 pmol (50 nM) Stealth™ siRNA control (siControl) or
Stealth™ siRNA specific to Aldhlal (siAldhlal) using Lipofectamine™ RNAiMAX
(Invitrogen) according to maimfacturer's instructions. To test the effect of stealth siRNA
on Aldhlal gene expression, the mRNA levels and protein levels were analyzed 48 h
after transfections by qRT-PCR and Western blot, respectively.

Measurement of Cell Viability by MTT assay

Hepa-lclc7 cell viability was evaluated using an MTT assay according to
manufacturer's instruction. Hepa-lc1c7 cells (5,000 cellsllOO I.d) were plated in a 96well plate. Cells were treated with increasing concentrations of acrolein (0 to 100 flM) in
serum free media for 24 h. Cells were then incubated with MTT (0.2 mg/ml) for 2 hand
cell viability was assessed by measuring the absorbance at 570 nm.

RNA Isolation and Quantitative Real Time PCR (QRT -PCR).
RNA was isolated from Hepa-lc1c7 cells or mouse liver using TRI reagent
(Molecular Research Center, Inc., Cincinnati, OH). The mRNA levels of Aldhlal,
Aldhlbl, Aldh2 and Aldh3al were assessed by qRT-PCR. Total RNA isolated from cells
was reverse transcribed to cDNA with random hexamer primers using the Advantage RTfor-PCR kit (Clontech, BD Bioscience, Palo Alto, CA). RNase H was then used to
degrade any residual RNA in the cDNA mix. QRT-PCR was performed using the ABI
7900HT Sequence Detector System (Applied Biosystems, Foster City, CA) with gene
specific FAM-labeled LUX primers synthesized by Invitrogen (Carlsbad, CA). A plot of
the CT versus quantity of RNA was generated to verify linearity of amplification. All
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qRT-PCR experiments were performed in triplicate using cDNA sample from
independent RNA set and analyzed by the absolute quantitation standard curve method.
The gene expression levels were normalized to 18S rRNA as endogenous control and
data were expressed as the mean ± SD. Samples were analyzed by Student's t test and
values of p < 0.05 were considered to be statistically significant.

Western Immunoblotting.
Whole cell extracts were prepared from Hepa-lclc7 cells using IX RIPA buffer
(20 mM Tris-HCI,pH 7.5; 150mMNaCI, 1 mMNa2EDTA, 1 mMEGTA, 1% NP-40,
1% sodium deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM p-glycerophosphate, 1
mM Na3 V04, 1 Ilg/mlleupeptin; Cell Signaling Technology, Beverly, MA) containing
protease inhibitors (Protease Inhibitor Cocktail Set III, EDTA free; Calbiochem, La Jolla,
CA). For determination of acrolein-protein adducts in cells, a modified IX RIP A Lysis
buffer containing 50 mM NEM was used. Protein concentration was measured using
Pierce® BCA Protein Assay (Pierce, Rockford, IL). Lysates were resolved on 4-12%
NuPAGE® Novex® Bis-Tris mini gels and transferred onto Amersham Hybond™-ECL
nitrocellulose membranes (GE Amersham Pharmacia Biotech, Piscataway, NJ).
Membranes were probed with antibodies against rat ALDHI (1 :2000), Caspase 3
(1: 1000) or GAPDH (1: 10000) at room temperature for 2 h or acrolein-protein adducts
(1 :2000) and cleaved Caspase 3 (1: 1000) at 4°C overnight. The membrane was incubated
with horseradish peroxidase-conjugated goat anti-rabbit (Sc-2004, Santa Cruz
Biotechnology) or goat anti-mouse (Sc-2005, Santa Cruz Biotechnology, Santa Cruz,
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CA) secondary antibody and the transferred proteins were visualized with Amersham
ECL Plus western blotting detection system.

RESULTS
Expression, Purification and Biochemical Characterization of Recombinant
Aldhlal, Aldh2 and Aldh3al
We examined the kinetic parameters (Km, V max and V max/Km) of recombinant
mouse Aldhlal, Aldh2 and Aldh3al (Table 1) for oxidative metabolism ofa wide range
of aldehyde substrates and the OS conjugates of HNE using either NAD+ or NADP+ as
pyridine nucleotide cofactor. The cofactor preference of recombinant mouse ALDH was
also assessed using varying concentrations of either NAD+ or NADP+. Kinetic
parameters indicate that mouse Aldhlal exhibited high affinity for short chain aldehydes,
such as propionaldehyde (Km = 141 flM) and acetaldehyde (Km = 202 flM) and the lipid
aldehydes; acrolein (Km = 23.2 flM), trans-2-hexenal (Km = 31.2 flM), HNE (Km = 2.4
flM) and MDA (Km = 7.5 flM) as shown in Table 1. The catalytic efficiency for Aldhlal
was highest for HNE (V max/Km = 218) and lowest for benzaldehyde (Vmax/Km = 0.3).
Mouse Aldhlal had an apparent Km of752 flM for benzaldehyde, indicating that the
aromatic aldehydes, benzaldehyde is a poor substrate for Aldhla1. Aldhlal preferred
NAD+ (Km = 50.2 flM) as cofactor, and displayed no catalytic activity with NADP+. The
order of the catalytic efficiency of mouse Aldhlal for aldehyde substrates, as reflected by
V max/Km was HNE > MDA > acrolein> trans-2-hexenal > propionaldehyde >
acetaldehyde> benzaldehyde. The catalytic efficiency for Aldh2 was highest for
acetaldehyde (V max/Km = 22) followed by propionaldehyde (V max/Km = 13). This result is
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consistent with the human ALDH2. In Table 1, we observed that benzaldehyde is also a
poor substrate for Aldh2. The affinity of Aldh2 for lipid aldehydes was considerably
lower than that of Aldhlal, acrolein (Km = 72.5 flM) and HNE (Km = 161 flM). The rate
of metabolism ofGSH conjugate ofHNE (GS-HNE) by Aldhlal and Aldh2 were lower
compared with free HNE. Again, Aldhlal showed higher catalytic efficiencies (;::::;3.6
fold) for metabolism of GS-HNE compared with Aldh2.
Due to the extremely high V max of Aldh3al (flmol/min/mg) for most aldehyde
substrates compared with that of Aldhlal and Aldh2 (nmol/min/mg), the catalytic
efficiency of Aldh3al was higher for most aldehyde substrates except for the lipid
aldehydes. In contrast to Aldhlal, mouse Aldh3al exhibited high affinity for aromatic
aldehyde, such as benzaldehyde (Km = 37 flM) followed by the lipid aldehydes and
showed poor affinity for short chain aldehydes, such as propionaldehyde (Km = 3380 flM)
and acetaldehyde (Km = 1000 flM). Aldh3al was capable of metabolizing lipid
aldehydes, such as acrolein, HNE and MDA with low affinity for substrate binding (Km
>300 flM) compared with Aldhlal. In addition, both Aldh2 and Aldh3al used NAD+ and
NADP+ as cofactor for oxidative metabolism of aldehydes, but preferred NAD+
(Aldh3al, Vmax/Km = 484; Aldh2, Vmax/Km = 14) overNADP+ (Aldh3al, Vmax/Km = 87;
Aldh2, V max/Km = 0.6). The catalytic efficiencies for metabolism of acrolein were
comparable between Aldhlal and Aldh3al (Vmax/Km = 23). However, Aldhlal exhibited
far higher relative affinity for acrolein (Km = 23.2 flM) compared with Aldh3al (Km =
464 flM). Furthermore, the Aldhlal displayed high catalytic efficiency for HNE
compared Aldh3al, suggesting that reactive lipid-derived aldehydes were preferred
substrates for Aldhlal.
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Table 1. Kinetic properties of recombinant mouse Aldhs.
Aldh enzyme activity was determined by monitoring the formation ofNADH at 340 nm
as previously described by Lindahl and coworkers (Lindahl and Petersen, 1991). Enzyme
activities were measured spectrophotometrically at 25°C in a reaction mixture containing
1 mM NAD+ at pH 7.4. The kinetic parameters were determined using non-linear
regression software Kineti77. The values represent the means ± SD from 3-4 assays. The
kinetic parameters for NAD+ and NADP+ were determined using 1 mM propionaldehyde
(Aldhla1 and Aldh2) or 2.5 mM benzaldehyde (Aldh3al) as the substrate.
a

Unit is nmol/minlmg;

b

Unit is flM;

C

Unit is ml/minlmg; and,

d

Unit is flmol/minlmg.
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Table 1

A}(lhlal

Substrate

w

Vmaxa

Kmb

AMh3~11

Aldh2
Vmaxikmc

V maxa

Kmb

Vmax/kmc

Vmaxd

Kb
m

Vmaxil{mC

Propionaldehyde

799 ± 21

141 ± 30

5,6

619 ± 129

49 .... ± 13

13

2-1.7 ± 1.2

3380 ± 3&

.,

Acet<llclehyde

910 ± 36

202 ± P

4,5

751 ± 116

35." ± 14

22

32 .... ± 1.0

1000 ± 20

32

B e1lZ<lldehyde

256 ± 14

752 ± 90

0.3

120 ± 24

1911 ± 33

0,1

28.6 ± 1.6

J7 ± 6

7"'3

Trans- 2-hexenal

390 ± 3 7

31.2 ± 4,1

12,)

ND

ND

ND

28.1 ± 1.1

236 ± 40

119

HNE

522 ± 26

2.... ± 0.9

21&

489 ± 58

161 ± 41

3

29.5 ± 3.7

425 ± 94

69

Acrolein

5li ± 22

23.2 ± 4.3

13

543 ± 36

71.5±15

7.4

10.3 ± 1.1

464 ± 85

23

11<110 ndiald ehyde

408 ± 15

7.5 ± 1.2

54

ND

ND

ND

83 ± 0.7

302 ± 52

..

NAD+

751 ± 7

50.2 ± 4

L'i

764 ± 49

56 ± 6.&

L,(6

26.9 ± 5.9

55.5 ± 2.3

484

NADP

ND

ND

ND

177 ± 16

181 ± 37

0.6

28 ± ;,.5

320 ± 18

37

GS-HNE

112±3

32.5 ± 4.4

3.6

161 ± 26

18-t±13

1.0

ND

ND

)":'
/

ND

Expression of Aldehyde dehydrogenases in mouse liver and mouse hepatoma cell
lines

To assess which Aldh isoform plays a prominent role in oxidative metabolism and
detoxification of reactive lipid aldehydes in mouse liver, we assessed the mRNA levels of
the major Aldhs expressed in mouse liver and Hepa-IcIc7 cells by qRT-PCR. The
Aldhi al gene was highly expressed in mouse liver and Hepa-I c1 c7 cells compared with
Aldh2, Aldhi bI and Aldh3aI (Figure 3). The mRNA levels of Aldh2 were expressed at
comparable levels in both mice liver and Hepa-Ic1c7 cells. However, Aldhi bi mRNA
expression was higher in Hepa-I c I c7 compared with mouse liver (;::;2-fold). As
previously demonstrated, Aldh3aI mRNA expression was extremely low in mouse liver,
but was moderately expressed in Hepa-Ic1c7 cells compared with AldhIal. Aldhial
mRNA levels were 34-fold and 73-fold higher than the Aldh2 mRNA levels in mouse
liver and Hepa-Ic1c7 cells, respectively. The order ofmRNA expression of the major
Aldhs involved in lipid aldehyde metabolism in mice liver and Hepa-Ic1c7 was Aldhial
> Aldh2 > Aldhibi > Aldh3al. We concluded from enzyme kinetics and gene expression
data that Aldhial most likely plays a prominent role in the cellular defense against
oxidative damage induced by cytotoxic aldehydes in mouse liver.
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Figure 3. Endogenous levels of aldehyde dehydrogenase gene expression in mouse liver
and mouse hepatoma cells. Total RNA extracted from the liver of C57BLl6 mice (n=5) or
Hepa-lclc7 cells was reverse transcribed to eDNA with random hexamer primers using
Advantage RT-for-PCR kit. The eDNA was used for analysis of gene expression of
Aldhlal , Aldh2, Aldhi bi and Aldh3aI by qRT-PCR. The qRT-PCR experiments were
performed in triplicate using eDNA from 5 separate murine liver sample sets. The gene
expression levels were normalized to 18S rRNA as endogenous control and data were
expressed as the mean ± SD.
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Knockdown of Aldhlal gene expression sensitized liver-derived cell lines to
acrolein-induced cell death
To specifically examine the role of AldhlaJ in cellular protection against reactive
lipid-derived aldehydes such as acrolein, we assessed whether knockdown of Aldhlal
gene expression sensitized Hepa-lclc7 cells to acrolein-induced cell death. Hepa-lclc7
cells were transfected with either Stealth control or Stealth Aldhlal-specific siRNA. The
effect of knockdown of Aldhlal gene expression was assessed by qRT-PCR and Western
blot. RNA was isolated from cells 48 h after transfection and was reverse transcribed to
cDNA. The cDNA was then used to assess Aldhlal mRNA expression normalized to
18S as endogenous control by qRT-PCR. In Figure 4A, we observed> 80% reduction in
Aldhlal mRNA levels in stealth Aldhlal-specific siRNA transfected cells compared
with untransfected control.
Cell extracts (40 Ilg) prepared from Hepa-lclc7 cells transfected with Stealth
control siRNA or Stealth Aldhlal-specific siRNA were separated on SDS-PAGE gels
and transferred onto nitrocellulose membrane. The membranes were probed with
antibodies against rat ALDHIAI and GAPDH as endogenous control (Figure 4B).
Densitometry analysis of Aldhl al protein levels corrected for GAD PH showed :::0 85%
reduction in Aldhla1 protein level in cells transfected with Stealth Aldhlal-specific
siRNA compared with untransfected control (Figure 4C). Subsequently, we assessed
whether Hepa-1c1c7 cells with knockdown of Aldh1a1 gene exhibit higher sensitivity to
acrolein-induced cell death. Twenty four hours after transfection ofHepa-1c1c7 cells
with either stealth control or Stealth Aldhla1 siRNA, cells were exposed to a range of
acrolein concentrations (0-100 IlM) for 24 h and cell viability was examined by MTT
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assay. Figure 3D showed that Hepa-lc1c7 cells exhibit higher sensitivity to acrolein, with
25 IlM and higher concentrations producing concentration-dependent decrease in cell

viability. We also observed a comparable dose-dependent decrease in viability between
untransfected and control siRNA transfected cells. However, knockdown of Aldhlal
gene expression resulted in marked decreased in cell viability compared with WT cells.
The half maximal effective concentrations (EC so) of acrolein for cells with low
expression of Aldhlal (EC so ~22 IlM) was significantly reduced compared with that of
the untransfected and control siRNA transfected cells (EC so

~35

IlM). These results

indicate that cells with low Aldhlal expression are highly vulnerable to acrolein-induced
cell death, suggesting that Aldhlal protects cells from reactive aldehydes-induced cell
death by enhanced metabolism of these reactive species.
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Figure 4.

Hepa-lclc7 cells with knockdown of Aldhlal gene expression by stealth

specific siRNA are highly sensitive to acrolein-induced cell death compared with control
cells. (A-C) Stealth specific siRNA mediated knockdown of Aldhlal gene in Hepa~lc1c7
cells. Hepa-lc1c7 cells were transfected with either 150 pmol (50 nM) Stealth control
(siControl) or Stealth Aldhlal-specific siRNA (siAldhlal) using Lipofectamine
RNAiMAX. (A) qRT-PCR analysis of Aldhlal gene expression in various Hepa-lclc7
cells. The mRNA expression of Aldhlal was examined by qRT-PCR and experiments
were performed in triplicate using cDNA sample from independent RNA set. The gene
expression levels were normalized to 18S rRNA as an endogenous control and data were
expressed as fold over WT. (B) Western blot analysis of Aldhlal expression in Hepalc1c7 cells. Cell extracts prepared from WT, siControl and siAldhlal cells were
separated on 4-12% SDS-PAGE gel and transferred onto nitrocellulose membrane.
Membranes were probed with antibodies against ALDHIA1. Membranes were stripped
and then reprobed with antibodies against GAPDH. The Western blot experiment was
performed in triplicate and the figure is a representative blot. (C) Densitometry analysis
of Aldhlal protein levels normalized to GAPDH in WT, siControl and siAldhlal Hepalc1c7 cells. (D) Knockdown of Aldhlal sensitizes Hepa-lc1c7 cells to acrolein
treatment. Twenty four h after transfection with Stealth siRNA control or Stealth
Aldhlal-specific siRNA, cells were treated with increasing concentrations of acrolein for
24 h and cell viability assessed by MTT (0.2 mg/ml for 2 h) at 570 nm as described in
Materials and Methods. The half maximal effective concentrations (ECso) were as
follows: WT untransfected cells (35.61 ± 1.64 J.lM), Stealth control siRNA transfected
cells (35.72 ± 1.62 J.lM) and Stealth Aldhlal-specific siRNA transfected cells (22.92 ±
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0.32 11M). The values are expressed as the mean ± S.E. and the EC so for SiAldhlal
ablated cells were statistically different that of control or SiControl cells (p :sO. 05).
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Increased acrolein-protein adducts in Hepa-lc1c7 cells with siRNA silencing of
Aldhlal gene expression
Acrolein and other highly reactive

a,~-unsaturated

aldehydes readily alkyl ate

proteins forming Michael addition adducts with a free carbonyl group. It is now known
that protein carbonylation by reactive aldehydes precedes the toxic process leading to cell
death (Burcham and Fontaine, 2001). We examined whether acrolein-protein adducts are
increased in cells with knockdown of Aldhlal after acrolein treatment. Hepa-lc1c7 cells
were transfected with either stealth control siRNA (siControl) or Aldhlal specific stealth
siRNA (siAldhlal). After transfection, cells were exposed to either 10 flM or 25 flM
acrolein for 24 h. Lysates prepared from cells were separated on SDS-PAGE and
transferred onto nitrocellulose membrane. The membrane was probed with antibodies
against acrolein-protein adducts and GAPDH (Figure 5A). The level of acrolein-protein
adducts of individual proteins was analyzed by densitometry corrected for GADPH using
UN-SCAN-IT gel 6.1 software (Silk Scientific Inc., Orem, Utah). Three protein bands
labeled PI, P2 and P3 were chosen for analysis of acrolein-protein adducts accumulation
in the siControl and siAldhlal cells following exposure to acrolein (10 flM and 25 flM)
(Figure SB). Densitometry analysis showed that acrolein-protein adducts content of PI
and P3 continued to increase in both siControl and siAldhal-treated cells up to 25 flM
acrolein. We also noticed accumulation of endogenous acrolein-protein adducts for
protein PI, P2 and P3 in siAldhlal-treated cells compared with siControl cells. In protein
1 and 3 (PI and P3), the level of acrolein-protein adducts were increased in Aldhlalspecific Stealth siRNA transfected cells compared with control siRNA-transfected cells
after treatment with 10 flM acrolein.
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Figure 5. The levels of acrolein-protein adducts in response to acrolein treatment were
increased in Hepa-lclc7 cells with knockdown of Aldhlal gene compared with control
siRNA-transfected control cells (A) Western blot analysis of acrolein-protein adducts in
Hepa-l c1 c7 cells transfected with either stealth control siRNA or Aldhl aI-specific
siRNA and exposed to acrolein. Lanes 1-2: untreated cells, Lanes 3-4: cells were treated
for 24 h with 10 flM acrolein. Lanes 5-6: cells exposed to 25 flM acrolein for 24 h.
Western blot experiments were performed in triplicate and the figure is a representative
blot. (B) Densitometry analysis of the levels of individual protein-acrolein adducts in
siControl (Stealth control siRNA transfected cells) and siAldhlal (Stealth Aldhlal
specific siRNA-transfected cells) in response to 10 flM and 25 flM acrolein. Samples
were analyzed by 2-tailed t-test and values of p < 0.05 were considered to be statistically
significant. *, significantly different from siControls; and #, indicates significantly
different from untreated siControl.
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However, for PI, P2 and P3, we observed elevated levels of acrolein-protein adducts in
siAldhlaI cells compared to siControl cells at 25

~M

acrolein treatment. These results

indicate that when Aldhlal protein levels are low, the impaired acrolein metabolism and
detoxification led to accumulation of acrolein-protein adducts.

Increased acrolein-induced Caspase 3 activation and apoptosis in Hepalc1c7 cells
after knockdown of Aldhlal gene expression
In addition to protein-acrolein adducts accumulation and cell viability, we
investigated whether knockdown of Aldhlal sensitized cells to acrolein-induced caspase
3 activation, a marker of apoptosis. Reactive lipid aldehydes are known to induce
oxidative stress by depletion of GSH (Ellis, 2007). Oxidative stress and acrolein-protein
or HNE-protein adducts have been implicated in induction of apoptosis (Tanel and
Averill-Bates, 2007;Xiao et aI., 2003). Previous studies demonstrated that HNE induces
activation of caspase 3 in human lens epithelia cells (HLECs), human leukemia cells
(HL-60) and neuroblastoma cell line (SH-SY5Y) (Cheng et aI., 2001 ;Choudhary et aI.,
2002;Zhang et aI., 2010). Inactive procaspase 3 (32 KDa) zymogen is activated by
proteolytic cleavage adjacent to Asp 175 into activated 17- and 19-KDa fragments. Thus,
the activation of caspase 3 is monitored by Western blot analysis of the cleaved
fragments. To examine whether Aldhial can protect cells against acrolein-induced
apoptosis, we transfected Hepa-l c 1c7 cells with Stealth Aldh 1aI-specific siRNA
(siAldhlaI) or Stealth control siRNA (siControl) for 24 h and cells were subsequently
exposed to 25

~M

acrolein for 24 h. Cell extracts separated by SDS-PAGE gels were

transferred onto nitrocellulose membrane and probed for cleaved caspase 3 fragments,
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Figure 6. Transient knockdown of Aldhlal gene expression sensitizes Hepa-lclc7 cells
to acrolein-induced caspase 3 activation and apoptosis. (A) Western blot analysis of
acrolein-induced caspase 3 activation. Hepa-lclc7 cells were transfected with Stealth
Aldhlal-specific siRNA (siAldhlal) or Stealth control siRNA (siControl) for 24 hand
cells were subsequently exposed to 25 11M acrolein for 24 h. Cell extracts prepared with
IX RIPA buffer were separated on SDS-PAGE gel and transferred onto nitrocellulose

membranes. The membranes were probed for cleaved caspase 3 with anti-cleaved caspase
3 antibodies and caspase 3 with anti-caspase 3 antibodies. Anti-cleaved caspase 3
(AspI75) antibody detects levels oflarge fragment (17/19 KDa) of activated caspase 3
resulting from cleavage adjacent to Asp175. Western blot experiment was performed in
triplicate and the figure is a representative blot. Densitometry was normalized to GAPDH
ofprocaspase 3 (B) and cleaved caspase 3 (17 and 19 KDa fragments) (C) in WT,
siControl- or siAldhlal-treated Hepa-Ic1c7 cells exposed to 25 11M acrolein. Positive (+)
control for caspase 3 cleavage was extracts from cytochrome c-treated lurkat cells
(#9663) and negative (-) control was extract from untreated lurkat cells. The results were
analyzed by Student's - test and values ofp < 0.05 were considered to be statistically
significant. *, significantly different from WT (p< 0.05; 2-tailed t-test).
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caspase 3 and GADPH as endogenous control (Figure 6A). The levels ofprocaspase 3
(Figure 6B) and cleaved caspase 3 (17 and 19 KDa fragments) (Figure 6C) in
untransfected cell (WT), siControl- and siAldh1a1-treated Hepa1c1c7 cells exposed to 25
11M acrolein were assessed by densitometry corrected for GADPH using UN-SCAN-IT
gel 6.1 software. The levels of procaspase 3 were moderately increased in WT and
siAldh1a1 cells after acrolein treatment. However, procaspase 3 protein levels were
slightly decreased in siAldh1 a1 cells in the absence of acrolein treatment. As expected,
the levels of the 17 and 19 KDa fragments of caspase 3 (active) were robustly increased
(;:::: 40-fold) when cells were exposed to acrolein compared to untreated WT cells or
control siRNA transfected cells. The 19 KDa fragment was moderately increased in
siAldh1a1 cells compared with WT and siControl cells after acrolein (25 11M) exposure
(Figure 6C). However, we observed elevated levels (;:::: 3-fold) of the 17 KDa fragment in
siAldh1a1 cells compared with WT and siControl cells after acrolein (25 11M) treatment.
These results indicate that Aldh1a1 knockdown cells exhibit high sensitivity to acroleininduced caspase 3 initiated apoptosis. We can conclude from these data that Aldh1a1 by
enhanced detoxification and metabolism of acrolein protects cells against apoptosis
induced by acrolein.

DISCUSSION
Comparison of Substrate Specificity for murine Aldhs
The relative contribution of Aldh isozymes in protection against aldehyde toxicity
is controversial. While earlier studies indicated that ALDH3A1 but not ALDH1A1
protects against cytotoxic lipid derived-aldehydes, most recent studies in eye lens of
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Aldh1a1-1- mice showed that ALDH1A1 can protect against these reactive aldehydes
(Choudhary et aI., 2005;Townsend et aI., 2001). The contribution of the different
isozymes of Aldh to oxidation of lipid derived-aldehydes has not been examined in the
liver, even though the liver is the major site for metabolism and biotransformation of
foreign compounds. In this study, we sought to clearly define which Aldh isoforms playa
major role in oxidation and detoxification of cytototic lipid-derived aldehydes in mouse
liver by enzyme kinetics and gene expression pattern. Having obtained purified
recombinant murine Aldhs expressed in E. coli, we performed enzyme kinetic analysis to
compare their relative capacity for clearance of various aldehydes. As seen in Table 1,
the catalytic efficiencies can best be compared using the V max/Km parameters. Aldh3a1
displays highest preference for aromatic aldehyde substrates and utilizes both NAD+ and
NADP+ as oxidizing pyridine nucleotide co factors with preference for NAD+. Although
Aldh3Al displays 20-112-fold higher V max values for most aldehyde substrates, the
Vmax/Km parameters demonstrate that Aldh1a1 is a better catalyst than Aldh3al for
oxidative clearance of a,~-unsaturated aldehydes. The human and murine Aldhla1
proteins exhibit similar V max/Km parameters with some differences (Xiao et aI., 2009).
The human ALDH2 (Marchitti et aI., 2008) and ALDH1BI (Stagos et aI., 2010) proteins
displayed significantly lower V max/Km parameters for the lipid-derived aldehydes than
Aldh1al. The substrate specificity of recombinant Aldhs for GS-conjugates ofHNE
indicates that GS-HNE is a good substrate for Aldh1a1 and Aldh2. However, both
enzymes display a Km value for GS-HNE that is much higher than the free HNE itself,
suggesting that free HNE is a better substrate for these enzymes than its GSH conjugate.
Aldhlal showed higher catalytic efficiencies (;::::3.6 fold) for metabolism of GS-HNE
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compared with Aldh2. Kinetic studies also demonstrate that GS-HNE is not a substrate of
Aldh3al. The conclusion taken from the data in this report and the literature is that the
catalytic efficiency for lipid aldehyde oxidation by Aldhlal is the highest reported,
suggesting its potential importance for metabolism of these toxic compounds.

Aldhlal is highly expressed in mouse liver and Hepa-lc1c7 cells
In Figure 3, we showed that Aldhlal is highly expressed in the livers of male
C57BLl6 mice and in mouse hepatoma Hepa-lclc cells relative to other Aldh enzymes.
The levels of Aldhlal mRNA were about 34-fold higher than that of the next more
abundant mRNA, Aldh2. There was much less Aldhlbl and Aldh3Al mRNA expression
in either liver or Hepa-l c 1c cells. This observation is supported by the data in Chapter
III, which demonstrate that acrolein caused a 3-fold induction of Aldhlal mRNA in male
mouse livers, while other forms of Aldh were not induced by treatment with acrolein,
providing a mechanism for the liver cell to respond to toxic aldehydes. In addition, it is
known that hepatic Aldhlal is also induced in animals treated with butylated
hydroxyanisole (Alnouti and Klaassen, 2008) or phenobarbital (Deitrich et aI., 1977).
These compounds are known activators of transcription factors such as activator protein 1
(API), nuclear factor-erythroid 2 related factor 2 (Nrf2), and constitutive androstane
receptor (CAR). These observations clearly demonstrate that mouse Aldhlal and
probably the human ortholog (ALDHlAl) are major protective enzymes against the
products of lipid peroxidation and other toxic aldehydes in the environment.
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Ablation of Aldhlal gene expression increases acrolein-induced cell death, acrolein
protein adducts, and caspase cleavage
As a method of assessing the role of specific gene products in toxicological
processes, an in vitro method using gene ablation allows one to test the role of specific
proteins in response to toxic agents. Because Hepa-Ic1c7 cells appeared to recapitulate
the spectrum of Aldhs expressed in mouse liver, we chose this cell system to test whether
ablation of Aldhlal protein and enzyme activity increases the sensitivity of these cells to
acrolein (Figure 4). Using Stealth™ siRNA knockdown technology, we documented that
transfection of Aldhlal-specific siRNA suppresses the levels of Aldhlal mRNA and
protein in Hepalc1c cells (Figure 4A-C). We then challenged these cells with increasing
concentrations of acrolein to assess the relative sensitivity to acrolein toxicity (Figure
4D). While the control siRNA had no effect on acrolein toxicity curve as measured with
MTT-dependent cell viability, transfection of Hepa-lc1c7 cells with Aldhlal-specific
siRNA caused a shift to the left in the acrolein toxicity curve, clearly demonstrating that
cells with Aldhlal ablation were statistically more sensitive to acrolein toxicity than
control siRNA transfected or untransfected cells. These results provide evidence of an
important protective role for Aldhlal against a,~-unsaturated aldehydes in mouse liver.
Previous experiments demonstrate that treatment of cells with acrolein led to
increased acrolein-protein adducts and enhanced caspase 3 activation resulting in
proteolytic cleavage ofPARP (Burcham and Fontaine, 2001;Tanel and Averill-Bates,
2007). We measured the levels of acrolein-protein adduct in cells transfected with
Aldh I a I-specific siRNA and noted that the levels of acrolein-protein adducts (P I, P2, P3)
were significantly increased relative to control siRNA transfected cells (Figures SA, B).
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In addition to PI, P2, and P3, low concentration (10 /-lM) of acrolein resulted in a larger
amount of lower molecular weight acrolein-linked proteins that was not seen at higher
concentrations, most likely due to less extensive cross-linking present in PI, P2, and P3.
This could be due to the use of non-reducing Western blot At higher acrolein
concentrations, these lower molecular weight protein-adduct species decreased in
amount, while the higher molecular weight forms increased significantly as a function of
acrolein concentration. In addition, caspase 3 cleavage to a 17 KDa fragment was
strikingly increased in siAldhlal transfected Hepa-lc1c7 cells exposed to 25 /-lM
acrolein, relative to untransfected or siControl transfected cells (Figure 6). These results
clearly demonstrate that the pro-apoptotic changes caused by acrolein and levels of
acrolein-protein adducts are increased under conditions of Alclhlal depletion.
In summary, we presented evidence that Aldhlal plays a major role in cellular
defense against oxidative damage induced by reactive lipid aldehydes in mouse liver.
Aldh 1al exhibits far higher affinity for acrolein and HNE compared with Aldh2 or
Aldh3al. The endogenous Aldhlal gene was highly expressed in mouse liver and liverderived cell lines compared with Aldh2 and Aldh3al. The knockdown of Aldhlal
expression by siRNA caused Hepa-lc1c7 cells to be more sensitive to acrolein-induced
cell death and resulted in increased accumulation of acrolein-protein adducts and caspase
3 activation. Thus, mechanisms to induce Aldhlal gene expression may provide a useful
rationale for therapeutic protection against oxidative stress-induced pathologies.

48

CHAPTER III
MOLECULAR MECHANISMS UNDERLYING TRANSCRIPTIONAL
REGULATION OF MOUSE HEPATIC ALDEHYDE DEHYDROGENASE IAI
BY ELECTROPHILES

INTRODUCTION
The ALDH gene superfamily encodes enzymes that catalyze the NAD(P)+dependent oxidation of aldehydes generated from a wide variety of endogenous and
exogenous processes to their corresponding carboxylic acids. There are 555 genes
encoding ALDH proteins with 172 of these genes found in eukaryotes (Sophos and
Vasiliou, 2003). At present, 19 functional ALDH genes have been identified in the
human genome. Among the Aldh isoforms, the cytosolic mouse Aldhlal plays a critical
role in oxidative metabolism of highly toxic lipid aldehydes and protects liver-derived
cells from the toxic effects oflipid aldehydes (Makia et aI., 2011). Lipid peroxidation
generates many aldehydes as by products, among which acrolein and HNE are
presumably the most toxic and harmful. These aldehydes are implicated in the
pathogenesis of oxidative stress-induced pathologies, such steatohepatitis,
atherosclerosis, myocardial ischemia/reperfusion injury, cataract and cancer.
Murine Aldhlal gene, previously known as Retinaldehyde dehydrogenase I
(Raldhl or Ahd-2) is found on chromosome 19 and spans 45 kb in length (Hsu et ai.,
1999;Hsu et aI., 2000). It contains 13 exons and encodes a protein of;::;501 amino acids
49

with a molecular weight of;:::;5 5 KDa. Mouse Aldh 1 gene shares 96% and 87% of its
amino acid sequence with rat ALDH1 and the human ALDHI respectively, indicating
that it is the mouse homologue of the human ALDHI gene (Hsu et aI., 1999). The tissue
distribution of mouse Aldhlal gene is similar to that ofhumanALDHI gene. It is highly
expressed in the liver, lung, kidney, eye lens, gonads and retina (Marchitti et aI.,
2008;Vasiliou Vet aI., 2004). Increased expression of Aldh1al gene in the liver and lens
has been postulated as a mechanism to protect these organs against cytotoxic aldehydesinduced cellular damage. Thus, an understanding of the molecular regulation of Aldh1a1
gene expression is of importance in ameliorating the toxic effects of carbonyl compounds
and in preventing oxidative stress-induced pathologies.
Although the human and mouse Aldhla1 gene have been cloned and the promoter
region characterized, little is known about the molecular mechanisms that regulate the
expression of this gene in mouse liver (Elizondo et aI., 2009;Hsu et aI., 1999). An
understanding of the factors controlling Aldhla1 gene expression may assist efforts to
control the progression of oxidative stress-mediated diseases. The expression of Aldh1a1
gene is regulated by a wide variety of endogenous and exogenous stimuli. Aldhla1
expression is reported to be enhanced by activators ofNrf2 (Hu et aI., 2006;Lee et aI.,
2003;Reddy et aI., 2007;Thimmulappa et aI., 2002). Recent studies indicate that oxidative
stress-mediated activation ofNrf2 induces the expression of antioxidant and electrophiles
detoxifying genes including Aldh1a1 in an in vivo mice model of renal
ischemialreperfusion injury (Leonard et aI., 2006). Furthermore, the basal expression of
Aldh1a1 gene was significantly reduced in Nrf2-I- mice compared with wild type (WT)
mice (LamIe et aI., 2008), suggesting that the basal expression of Aldh1a1 may be
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regulated by Nrf2. However, the signaling pathway involved in electrophile-induced
expression of Aldhlal gene is not completely understood. It is not yet known whether
Aldhlal gene is a direct target ofNrf2, since most activators ofNrf2 are also known
inducers of the AP-I proteins.
There is increasing evidence that acrolein and related aldehydes, such as HNE and
crotonaldehyde at non-toxic concentrations, are important signaling molecules and can
induce the expression of cytoprotective genes encoding antioxidant and electrophile
detoxification enzymes (Liu et aI., 2010;Ranganna et aI., 2002;Tirumalai et aI., 2002).
Interestingly, many of these cytoprotective genes are involved in metabolism and
detoxification of reactive aldehydes. The signaling pathways involved in reactive
aldehydes-induced expression of cytoprotective genes are not completely understood.
However, reactive aldehydes are known activators of redox-responsive transcription
factors, namely nuclear factor-erythroid 2 related factor 2 (Nrf2), nuclear factor kappa B
(NF-KB) and members of the activator protein I (AP-I) family (Kwak et aI., 2003;Park et
aI., 2005;Pugazhenthi et aI., 2006;Ranganna et aI., 2002;Tirumalai et aI., 2002;Wu et aI.,
2006;Zhang and Forman, 2008).
Nrf2 and AP-I transcription factors are hepatoprotective against oxidative and
electrophilic stress by transcriptional up-regulation of antioxidant and electrophile
detoxifying genes. The activation ofNrf2 by electrophiles is known to disrupt its
association with Keap-l leading to Nrf2 translocation and nuclear accumulation. In the
nucleus, Nrf2 heterodimerizes with the small Maf proteins and binding to specific
response elements termed ARE/EpRE coordinates expression ofhepatoprotective genes.
AP-l proteins are also a binding partner for Nrf2. However, AP-l transcription factors
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preferably modulate gene expression as either homodimers ofjun family or heterodimers
with members oftheJos family. There is now compelling evidence to indicate that AP-l
proteins are hepatoprotective especially against oxidative and electrophilic stress. AP-l
proteins were shown to be cytoprotective against apoptosis induced by UV irradiation or
TNFa exposure (Weitzman et aI., 2000;Lamb et aI., 2003). Moreover, JunD regulates the

expression of human ferritin H genes which is protective against oxidative stressmediated cytotoxicity (Tsuji, 2005). Hasselblatt et ai. demonstrate that hepatocyte
survival during acute hepatitis was dependent on c-Jun/AP-1-induced expression of
inducible nitric oxide synthase (nos2) gene (Hasselblatt et aI., 2007). However, there has
been no report on the role of the redox-sensitive transcription factors, AP-l and Nrf2 in
the regulation of Aldhs and detoxification of lipid peroxidation.
The purpose of this study was to investigate whether well-known electrophiles
modulate the expression of Aldh1a1 in mouse liver and to elucidate the signaling
pathways involved. Gene expression profiles in the liver by acrolein and BHA were
analyzed by microarray to examine whether acrolein or BHA exposure up-regulates the
expression of genes encoding antioxidant or electrophile detoxification enzymes in mice
liver (Amunom, Makia and Prough, unpublished). Mice were administered AIN76A
(control) diet, diet containing 0.45% BHA or 5 mg/kg acrolein by gavage for 7 days. The
expression of genes encoding several electrophile detoxifying enzymes such as Gstm 1,
Gsta3, Gstp, Gstz 1, Akr 1c13, Akr 1c 19, Akr 1c20 and Akr 1a4 was specifically elevated
C:::2-fold), indicating a detoxification and antioxidant response. The elevation of Aldhla1
gene was noticeable with a 2- to 3-fold increase by both electrophiles. These results
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support a model in which high acrolein levels in cells stimulate Aldhlal gene expression,
thereby enhancing acrolein metabolism.

In vivo, BHA is oxidatively demethylated by cytochrome P450 to tertbutylhydroquinone (t-BHQ) with an oxidizable I, 4-diphenolic structure. The resultant tBHQ can undergo redox cycling by two-electron oxidation to tert-butylbenzoquinone
(tBQ) generating semiquinone radicals and ROS (Abiko et aI., 2011;Nakamura et aI.,
2003;Pinkus et aI., 1996). Even though, BHA is a known activator ofNrf2, studies by
Pinkus et al demonstrated that BHA-induced expression of GST-Ya gene is mediated by
induction of AP-1 activity (Pinkus et aI., 1996). Compelling evidence was presented
showing that the induction of AP-1 transcriptional activity by BHA or t-BHQ is due to
quinone-mediated generation of oxygen radicals and oxidative stress. However, the
metabolite of t-BHQ, similarly to acrolein, can act as an e1ectrophile and reacts with
intracellular nucleophiles including protein thiol and GSH by Michael addition reactions,
resulting in protein alkylation and GSH depletion. GSH-tBHQ conjugates have been
detected in cells exposed to t-BHQ (Nakamura et aI., 2003). As an electrophile, t-BHQ
can also cause dissociation of the Keapl-Nrf2 complex through covalent modifications of
cysteine residues (C 257 , C273 , C288 and C297 ) on Keap-1, resulting in nuclear accumulation
ofNrf2 (Nguyen et aI., 2004;Rushmore and Pickett, 1991).
In this chapter, we focus on electrophile-mediated regulation of Aldhlal in mouse
liver. The mRNA expression and activity of Aldhlal in liver from mice treated with
BHA or acrolein were measured by qRT-PCR and Aldh activity assay, respectively.
Second, we examined the signaling pathway involved in BHA- or acrolein-mediated
induction of Aldhlal gene expression. Since the major function of Aldhla1 is to detoxify
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highly toxic lipid aldehydes, the induction of Aldhlal gene in mice liver might be a
mechanism to alleviate toxicity associated with lipid peroxidation and could represent a
useful strategy for preventing oxidative stress-associated diseases.

EXPERIMENT AL DESIGN and METHODS

Chemicals
Tert-butylhydroquinone (t-BHQ), propen-2-al (acrolein), TRIzol®, SP600125
(JNK inhibitor), PD98059 (MEK inhibitor) and okadaic acid (phosphatase inhibitor) were
purchased from Sigma-Aldrich Company, Inc. (St Louis, MO). AIN-76A diet and AIN76A diet containing butylated hydroxyanisole (BHA) were obtained from Purina
Laboratories. Anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody,
clone 6C5 (MAB374) was purchased from Millipore (Temecula, CA). Rabbit polyclonal
antibodies against c-Jun (N; sc-45), Jun D (329; sc-74), Nrf2 (C-20; sc-722), JNK (FL;
sc-572) and pJNK (G-7; sc-6254), horseradish peroxidase-conjugated goat anti-rabbit
(Sc-2004) and goat anti-mouse (Sc-2005) were purchased from Santa Cruz
Biotechnology, Inc (Santa Cruz, CA). Phospho c-Jun (Ser63 II) antibody (#9261) was
obtained from Cell Signaling Technology (Danvers, MA).

Animals Genotyping and Treatment
Wild type (WT) and Nrf2 knockout (Nrf2-I-) male mice (C57BU6, 22 g to 27 g)
were obtained from the Breeding Colony of Roberto Bolli, University of Louisville. In
order to ensure pure genetic lines, genotypes were examined by PCR analysis of genomic
DNA isolated from tails. Mice were maintained on AIN76A chow (Purina) diet or pairedfed AIN-76 diet containing 0.45% BHA (Purina Test Laboratories) for 7 days. Acrolein
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(5 mg/kg body weight) was administered by gavage for 7 consecutive days while on
AIN-76A diet. Control mice were either fed AIN76A diet or chow diet with water
administration by gavage for the BHA and acrolein experiments, respectively. The mice
were sacrificed 24 h after the last treatment and the livers were harvested and stored at 80°C until used. Procedures were performed in accordance with approval by UofL
Institutional Animal Care and Use Committee (IACUC).

RNA Isolation and Quantitative RT -peR.
RNA was isolated from mice liver or Hepa-IcIc7 using TRI reagent (Molecular
Research Center, Inc., Cincinnati, OH) following standard protocol. Briefly, :::::O.1g of
frozen liver tissue was homogenized in I ml of TRI reagent (Invitrogen, Carlsbad, CA).
The RNA was purified using silica membrane spin columns (RNeasy reagent; Qiagen,
Valencia, CA). The RNA integrity was assessed by running a I % agarose gel and
quantified using the Nano Drop spectrophotometer. The RNA was ali quoted and stored at
-80°C until used.
The mRNA levels of Aldhlal, AldhIa7, Aldhlbl, Aldh2, and the Nrfl regulated
genes (Ho-I, Nqo-I and Gstml) were assessed by qRT-PCR according manufacturer's
instructions for absolute quantitation standard curve method. Briefly, total RNA isolated
from mice liver or Hepa-l c 1c7 were reverse transcribed to cDNA using the Advantage
RT-for-PCR kit (Clontech, BD Bioscience, Palo Alto, CA) with random hexamer
primers. RNase H was then used to degrade any residual RNA in the eDNA mix. QRTPCR was performed using the ABI 7900HT Sequence Detector System (Applied
Biosystems, Foster City, CA) using gene specific FAM-Iabeled LUX primers
(Invitrogen). The primer specificity was determined by BLAST analysis of predicted
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PCR products and the confirmation of a single PCR product by the melting curve
analysis. A plot of the CT versus quantity of RNA was generated to verify linearity of
amplification. All qRT-PCR experiments were performed in triplicate using cDNA
sample from independent RNA sets and analyzed by the absolute quantitation standard
curve method. All gene expression levels were normalized with 18S rRNA as
endogenous control. QRT-PCR experiments were performed in triplicate using cDNA
sample from independent RNA sets and data were expressed as the mean ± SD and
analyzed by Student's t test. Values ofp < 0.05 were considered to be statistically
significant.

Cytosolic ALDH Activity
The hepatic Aldh activity was examined in the cytosolic fractions isolated from
the liver of male C57BL6 mice (Jackson Laboratories, Bar Harbor, MA) treated daily
with acrolein (5 mg/kg by gavage) or sulforaphane (10 mg/kg by gavage) for 7
consecutive days or placed on BHA diet (0.45% BHA in AIN76 diet) for 7 days and
sacrificed 24 h after the last treatment. All procedures were performed following IACUC
guidelines. The liver cytosolic fraction was isolated following protocol adapted in the
Prough laboratory for preparation ofliver microsomes (Remmer et aI., 1966). Briefly, the
livers were excised and cut into small pieces with scissors in a beaker of saline and
homogenized in 0.25 M sucrose buffered with 50 mM potassium phosphate buffer (PH
7.4). The homogenized liver was then centrifuged at 1000 rpm for 10 min. Further
sedimentation at 12000 rpm for 20 min was then done in the same tube. The supernatant
was then decanted leaving 5-10% of the supernatant with the pellet. The supernatant was
sedimented at 108,000g for 1 h. To stabilize the enzymes, 20% glycerol was then added
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to the supernatant or cytosolic fractions and stored at -80°C. The Aldh activity was
measured spectrophotometrically as described in Chapter II using 1 mM propionaldehyde
(substrate specific for Aldhl al) as substrate.

Western blotting
Hepa-l c1 c7 cells were treated with increasing doses of acrolein as described in the figure
legends. Cells were harvested at different times and Western blot was essentially
performed as described in the Method of Chapter II. HepG2 cells were also transfected
with c-Jun or Nrf2 expression plasmids. Membranes were probed with antibodies against
rat ALDHl (1 :2000) and GAPDH (1: lOOOO) at room temperature for 2 h or c-Jun
(1 : lOOO), Jun D (1 : 1000), Nrf2 (1: lOOO) and phospho c-Jun (1: lOOO), JNK (1: lOOO) and

phospho JNK (1 : lOOO) at 4°C overnight. The membrane was incubated with horseradish
peroxidase-conjugated goat anti-rabbit (1: 10000) or goat anti-mouse secondary (1: 10000)
antibody and the transferred proteins were visualized with Amersham ECL Plus western
blotting detection system.

Transcription Factor Binding Sites Analysis
The putative transcription factor binding sites of the murine Aldhlal 5'-flanking
region (-80001+27 bp) was analyzed by Genomatrix MatInspector and Transfac software
with emphasis on the binding sites for Nrf2 (A/GIGACNNNGC) and AP-I

(AIGAC/GICA). Putative AREs and IRE were identified in the proximal promoter of
Aldhlal, suggesting that electrophile-mediated transcription of Aldhlal may be
regulated by either Nrf2 or AP-l. We cloned an :::::;2.0 kb fragment of mouse Aldhlal
proximal promoter that contains these putative ARE and IRE, upstream of pGL3 basic
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luciferase reporter vector using mouse genomic DNA (Promega, Madison, WI) as our
template in PCR reaction.

Plasmids and Cloning of Aldhlal Promoter Region
Mouse genomic DNA was purchased from Promega (Madison, WI) and used in
PCR experiment to generate 2,002 bp of mouse 5'-flanking sequence. This region
contains -1963/+23 bp relative to the transcription start site (TSS) of mouse Aldh1a1
gene. The upstream primer (5'-GGTACCAAATGGGCAGGCATGGTAAC-3') was
designed to introduce a Kpn 1 site while the downstream primer (5' AGATCTTGGTTTGGCTCCTGGAACAC-3 ') introduced a HindIII site. The PCR
product was recovered into a pCR2.1 vector (Invitrogen, Carlsbad CA). The identity of
the sequences of the PCR products was confirmed by sequence analysis in the University
of Louisville, Center for Genetics and Molecular Medicine Nucleic Acid core facility.
Kpn1 and HindIII enzymes were used to subclone the 2002 bp Aldh1a1 promoter region
into the pGL3-Basic vector to generate -1963/+27 Aldh1a1-Luc constructs.
The expression plasmid for c-fos (pRSV-cfos) and c-jun (pRSV-cjun) were
provided by Pickett C.B and Nguyen T (Schering-Plough Research Institute, Kenilworth,
New Jersey). The expression plasmid for Jun D (pcDNA3.1-JunD), Jun B (pcDNA3.1JunB), Fra-1 (pcDNA3.1-Fra1) and Fra2 (pcDNA3.1-Fra2) were kind gifts from Sunita
K. Agarwal (NIDDK, NIH). The Nrf2 expression plasmid (pCI-Nrf2neo) was donated by
K.S. Ramos (University of Louisville). The Plasmid 0.1 64GSTYa-ARELuc (0.164YaARELuc) containing 164 bases of the rat GST -Ya minimal promoter with a consensus
ARE cloned upstream ofthe luciferase reporter gene was used as a positive control for
Nrf2-dependent regulation of gene expression (Falkner et aI., 1998). A construct
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containing the human collagenase TRE (pCoITRELuc) was generated by Immaculate
Amunom at the Prough laboratory. This plasmid was previously used as a positive
control for AP-l transcription activity.

Transfection of HepG2 Cells and Luciferase Reporter Assays
The human hepatoma cell line HepG2 (HB8065, American Type Culture
Collection, Rockville, MD) was maintained in Eagle's minimal essential media with 10%
fetal bovine serum (HyClone, Logan UT), 1% antibiotic-antimycotic solution (containing
penicillin, streptomycin and fungizone; Invitrogen; Carlsbad CA) and non-essential
amino acids (1X; Mediatech Inc. Herndon VA). Cells were plated at a density of
approximately 150,000 cells/ml per well in 12-well plate. After plating, cells were
transfected using 1 flg/2.5 flL of Lipofectamine L TX and 1 flL of Plus (Invitrogen,
Carlsbad, CA) with 250 ng/well ofpGLO.5-1684Aldhla1, pGL1.5-1684Aldh1a1, 1963/+27Aldh1al, -1496/+27 Aldh1a1-Luc, -1005/+27 Aldhlal-Luc, -480/+27Aldh1a1Luc, pO. 164GSTYa-ARELuc or pCoITRELuc. The cells were co-transfected with
varying amounts ofpRSV-cfos (0-80 ng), pRSV-cjun (0-80ng) or pCI-Nrf2neo (0-100
ng). After incubation at 37°C for 24 h, the transfection media was replaced with 1 ml
media containing 10% FBS and then cells were treated when necessary with 0.1 % DMSO
or t-BHQ. The cells were harvested after overnight incubation
Luciferase ceUlysis buffer (Promega, Madison, WI). The

(~17-24

h) with 100)J.L of

~-galactosidase

and luciferase

activities were determined as described by Falkner et al (1998). The data were expressed
as luciferase activity relative to

~-galactosidase

activity to normalize for transfection

efficiency. All transient transfection experiments were performed in triplicate and
experiments were repeated at least twice for confirmation. Statistical comparisons among
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treatment groups were determined using a two-tailed t-test, with p<0.05 as a criterion for
significance.

RESULTS
Induction of Aldhlal gene expression by acrolein and BHA in mouse liver
Kinetic studies with recombinant Aldhlal enzyme showed that reactive lipidderived aldehydes, such as acrolein and HNE are good substrates of Aldhlal. These
aldehydes are implicated in the pathogenesis of many oxidative stress-induced diseases.
Thus mechanisms to induce the expression of Aldhlal might be beneficial against these
pathologies. Previous studies demonstrate that the expression of Aldhlal gene is
modulated by a wide variety of endogenous and exogenous stimuli (Alnouti and
Klaassen, 2008;Leonard et aI., 2006). Microarray studies in the Prough laboratory
indicated that acrolein feeding up-regulated Aldhlal (;::::; 2-fold) gene expression in mouse
liver (Amunom, Makia and Prough, unpublished report). Hepatic Aldhlal mRNA levels
were also induced (;::::;3-fold) by treatment of mice with other electrophiles, BHA. To
confirm these microarray data, we 'examined whether acrolein or BHA can induce the
expression of Aldhlal gene in mice liver. C57BLl6 mice on laboratory chow diet were
treated with water (control) or 5 mg/kg acrolein by gavage daily for 7 days. The daily
human consumption of unsaturated aldehydes is estimated to be ;: : ; 5 mg/kg and no
hepatocellular damage was observed in mice exposed to this dose of acrolein (Conklin et
aI., 2010), showing that 5 mg/kg is a sublethal concentration of acrolein. However,
significant damage to the liver was observed when mice were administered an acrolein
dose of 10 mg/kg. Mice on AIN76 diet were also administered SFN (10 mg/kg) daily by
gavage or fed AIN-76 diet containing 0.45% BHA for 7 days. Total RNA extracted from
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the liver was used for qRT-PCR analysis of gene expression of AldhJ aJ, GstmJ, Nqo-J
and Ho-J (Figure 7). Aldhlal mRNA levels were significantly increased in mice liver by
acrolein (:::::; 3-fold) or BHA (2.5-fold) treatment compared with control. The mRNA
expressions of Aldh1a1 were also significantly increased when Hepa-1clc7 cells were
treated with 20 /lM acrolein for 6 h compared with control (Figure 8). As expected,
acrolein treatment caused induction of antioxidant and electrophile detoxification genes,
such as Gstml, Nqo-l and Ho-l gene in mice liver. The mRNA expression ofGstml,
Nqo-l and Ho-l were also increased by BHA treatment in mice (Figure 7).
Even though, Ho-l and Nqo-l genes were significantly induced by SFN in mice
liver, no induction of Aldhlal and Gstml gene expression was observed with SFN
(Figure 7). These results suggest that the mechanism of induction ofHo-l and Nqo-l
gene expression by electrophiles differs from that of Aldhlal or Gstml. The
isothiocyanate, SFN is a known activator ofNrf2 (Nguyen et aI., 2009), while BHA and
acrolein are known to induce gene expression by activation of either Nrf2 or AP-l (Choi
and Moore, 1993;Lee and Murray, 2010). We conclude from Figures 7 and 8 that the
signaling pathway involved in electrophile-mediated induction of Aldhlal gene differs
from that ofNqol and Ho-l.
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Figure 7. QRT-PCR analysis of electrophile detoxification gene expression in the liver of
mice treated with acrolein, BHA or SFN. For the acrolein experiment, C57BLl6 mice on
laboratory chow diet were treated with water (control) or 5 mg/kg acrolein by gavage
daily for 7 days . For BHA and SFN experiment, C57BLl6 mice on AIN-76 diet were
placed on diet containing 0.45% BHA for 7 days or administered 10 mg/kg SFN daily for
7 days by gavage (n= 4-5). Total RNA was extracted from the liver, reverse-transcribed
to cDNA and qRT-PCR analysis of AIdhI aI , Gstml , Nqo-I and Ho-I gene expression
was performed as described in Materials and Methods.
significance compared to controls (p<0.05).
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Figure 8. Acrolein induces the mRNA levels of cytoprotective genes encoding
antioxidant and electrophile-detoxification enzymes in Hepa-I cl c7 cells. Cells were
untreated (control) or treated for 6 h with 20

~M

acrolein. Total RNA was extracted from

the cells, reverse-transcribed to eDNA and gene expression in relation to I8S was
measured by qRT-PCR in triplicate using eDNA from independent sample sets.
indicates statistical difference compared with controls (p<0.05; 2-tailed t-test).
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Hepatic cytosolic Aldh activity was induced in mice treated with acrolein (::::::4fold) or BRA (::::::4.5-fold) when 1 mM propionaldehyde and NAD+ was used as substrate
and cofactor, respectively (Figure 9). However, the acrolein- or BRA-induced Aldh
activity was nearly undetected when the assay was performed with NADP+ as pyridine
nucleotide cofactor. The major cytosolic Aldh isozymes are Aldhlal and Aldh3al. From
kinetic studies, we showed that propionaldehyde is a good substrate for Aldhlal and that
Aldhlal utilized solely NAD+ as cofactor. Moreover, since the mRNA levels of
endogenous Aldh3al gene in normal mice liver is negligible, the major isoform that
contributes to acrolein- or BRA-induced Aldh activity in mice liver is likely Aldhlal.
This is the first report to demonstrate induction of Aldh gene expression by acrolein in
mouse liver. Consistent with the mRNA expression, cytosolic Aldh activity was not
induced in liver of mice by SFN even at a dose of 10 mg/kg. These results validate our
micro array data which demonstrate the induction of hepatic Aldhlal gene expression and
other electrophile detoxification gene by BHA or acrolein. We postulate from the SFN
treatment results that Nrf2 may not be involved in electrophile-mediated induction of
Aldhlal gene.
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Figure 9. Increased liver cytosolic ALDH activity by BHA or acrolein in mice. C57BLl6
mice on normal chow diet were treated with water (control) or 5 mg/kg acrolein by
gavage daily for 7 days. For BHA and SFN experiment, C57BLl6 mice on AIN-76 diet
were placed on diet containing 0.45% BHA for 7 days or administered SFN (10 mg/kg)
daily for 7 days by gavage (n= 4-5). The liver was extracted and the cytosol obtained by
centrifugation at 108,000 x g for 1 h. Aldh activity was assessed by monitoring the
formation ofNAD(P)H at 340 nm as previously described by Lindahl and coworkers
(Lindahl and Petersen, 1991). The reactions rates were assayed spectrophotometrically at
37°C in a reaction mixture containing 1 mM propionaldehyde with either 1 mM NAD+ or
NADP+ as cofactor at pH 7.4. Specific activities (nmol/min/mg of protein) for cytosols
were 2.22 ± 0.24 (NAD+) and 15.8 ± 0.51 (NADP+) for controls; 9.97 ± 2.28 (NAD+) and
11.95 ± 0.88 (NADP+) for BHA-treated animals.
(p< 0.05 ; 2 tailed t test).
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* Significantly different from controls

Induction of Aldhlal gene expression by BHA in C57BL6 WT and Nrf2- I- mouse
liver
The mechanism of BHA- or acrolein-induced transcription of Aldhlal is not
completely understood. Previous studies have shown that the basal expression of Aldhlal
was significantly reduced in Nrf2-I - mice compared with WT. However, the mRNA levels
of Aldhlal gene were not up-regulated in mice with liver-specific knockout of the
negative regulator Keap-l, which showed constitutive activation ofNrf2. Our previous
results also indicated that Aldhlal gene expression was not induced by SFN, a known
activator ofNrf2 (Figure 7 and 9). However, the induction of gene expression by acrolein
and BHA is dependent on activation of redox-sensitive transcription factors, such as Nrf2
and AP-l. Thus, in order to assess the role ofNrf2 in electrophile-induced transcription
of Aldhlal, C57BLl6 WT and Nrf2-I - mice were exposed to 0.45% BHA for 7 days.
RNA was isolated from the mouse liver and the mRNA levels of Aldhlal and known
Nrf2 target genes, such as Gstml, Nqol and Ho-l, were examined by qRT-PCR.
The exposure of mice to BHA resulted in :::::2-fold increase in mRNA levels of
hepatic Aldhlal in both WT and Nrf2-I- mice compared with untreated control of the
same genotype (Table 2). However, the basal expression of Aldhlal was significantly
reduced in Nrf2-I- mice compared with WT control mice of the same genotype. The upregulation ofNqo-l, Gstml and Ho-l mRNA expression byBHA in WT mice was
significantly reduced in Nrf2- I- mice, suggesting that BHA-induced expression of these
genes is dependent on Nrf2. However, the induction of Aldhlal gene by BHA in WT
mice was not significantly different in Nrf2-I- mice. These results indicate that BHAinduced expression of Aldhlal is not mediated by Nrf2.
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Table 2
Effects ofNrf2 genotype on changes in mRNA levels of antioxidant and electrophile
detoxification genes in response to dietary BHA
Constitutive Levels

Inducible Levels

Fold Induction

Gene

Nrf2+I+

Nrf2-I-

Nrf2+I+

Nrf2-I-

Nrf2+I+

Nrf2-I-

Aldhlal

1.0

0.22

2.51

0.43

2.5*

2.0

Aldhla7

1.0

0.38

2.07

0.66

2.1 *

2.2

Aldh2

1.0

0.23

1.28

0.31

1.3

1.4

Aldhlbl

1.0

0.53

1.06

1.29

1.1

2.4**

Gstml

1.0

0.1

10.8

0.27

10.8*

2.6**

Nqol

1.0

0.11

8.8

0.48

8.8*

4.6**

Ho-I

1.0

0_77

2.84

1.09

2.6*

1.4**

Values are the average fold change per genotype in the liver of WT and Nrf2-I- mice.
QRT -PCR analysis of gene expression in the liver of C57BLl6 Nrf2+I+ and Nrf2-I- mice in
response to dietary administration of the phenolic antioxidant, BHA. Mice were fed either
AIN-76A diet (control, n=4) or diet supplemented with 0.45% BHA (treated, n=4) for 7
days. The Nrf2-I - mice were fed chow diet only (control, n=3) or diet supplemented with
0.45% BHA (treated, n=3). RNA extracted from the liver was reversed-transcribed to
form cDNA. The mRNA levels of Aldhlal, Aldhla7, Aldh2, Aldhlbl , Ho-l , Nqo-l and
Gstml genes were analyzed by qRT-PCR. The fold induction is shown. For each point, a
single mRNA was analyzed in triplicate and the average is shown.
significantly different from WT control (p<0.05; 2-tailed t test).
different from BHA-treated WT (p<0.05 ; 2-tailed t test).

67

* indicates

** indicates significantly

Induction of AP-l gene expression by acrolein or BHA in mouse liver
In order to examine whether electrophile-induced expression of Aldhlal gene is
dependent on AP-l, we assessed the mRNA levels of c-jun and c-fos in the liver of
acrolein- and BHA-treated mice. We observed significant induction of c-jun and c-fos
(::::2.0 fold) in WT mice after BHA treatment (Figure lOA). This induction was
significantly decreased in Nrf2-I- mice, suggesting that c-Jun and c-fos genes expression
are modulated by Nrf2. The expression of AP-l genes in WT and Nrf2-I- mice correlates
with that of Aldhlal gene (Figure 1OA). Thus, the low basal expression of Aldhlal in
I

Nrf2- - mice might be due to low levels of AP-I genes in these mice. We also observed

::::4.0-fold and 2.0-fold induction in the mRNA levels of c-jun and c-fos genes
respectively in the liver of mice after acrolein treatment (Figure lIA). The induction of
mRNA levels of c-Jun and c-fos gene by acrolein observed in Hepa-lc1c7 cells was
consistent with that observed in mouse liver (Figure llA). We hypothesized that
electrophile-induced expression of Aldhlal gene is mediated by AP-l proteins. To
further test our hypothesis, we assessed the protein levels and transcriptional activity of cJun in cellular extracts from WT mice exposed to BHA. Western blotting with antibodies
against c-Jun and phospho-c-Jun was performed in extracts from the liver of WT mice
exposed to control diet or diet containing BHA (Figure lOB). We observed significant
increases in both protein levels and phosphorylation status of c-Jun in BHA-treated mice
liver compare with control. To further test our hypothesis in Hepa-lc1c7, cells were
exposed to increasing concentrations of acrolein for 4 h and the expression and activity of
c-Jun were analyzed by immunoblotting (Figure lIB). Furthermore, Hepa-lc1c7 cells
were treated with acrolein (20 f-LM) at various time intervals and the activities of JNK and
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Figure 10. Effect ofBHA on c-jun and c-fos gene expression in mouse liver. (A) Nrf2+I+
or Nrf2- I - mice on C57BLl6 background were placed on AIN-76A diet (control, n=4) or
diet supplemented with 0.45% BHA (treated, n=4) for 7 days. QRT-PCR was used to
examine mRNA levels of c-jun and c-fos. (B) C57BLl6 mice were fed either AIN-76A
diet (control, n=4) or diet supplemented with 0.45% BHA (treated, n=4) for 7 days. Cell
extracts were separated on SDS-PAGE gel and transferred onto nitrocellulose
membranes. The membranes were incubated with antibodies against c-Jun (1 : 1000) and
phospho-c-Jun (1 : 1000; Ser 63) overnight at 4°C. (C) Densitometry analysis of c-Jun and
c-Jun activation in response to BHA. Western blot was repeated three times and the
figure is a representative blot.

* and # indicate statistical significant difference compared

with Nrf2+I+and Nrf2- I - controls, respectively (p<0.05 ; 2-tailed t-test).
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Figure 11 . Effect of acrolein on c-jun and c-fos transcriptional activity in mouse liver and
Hepa-Ic1c7 cells _A. C57BLl6 mice were treated with water (control, n=5) or 5 mg/kg
acrolein (treated, n=5) by gavage daily for 7 days _HepaIcIc7 cells were exposed to 20
/lM acrolein for 6 h. The mRNA levels of c-jun and c-fos were assessed by qRT-PCR.
B-C. Concentration- and time-dependent activation of c-Jun by acrolein. (B) Western blot
of c-Jun protein level and activity. Hepa-Ic1c7 cells were treated with varying doses of
acrolein for 4 h_(C) Cells were treated with 20 /lM acrolein at various time intervals.
Membranes were incubated with antibodies against c-Jun phospho Ser63 , c-Jun, JNKI /2
and p-JNKl /2. Western blot experiment was repeated three times and the figures shown
are representative blot. Densitometry analysis is indicated by number below each blot.
Statistical difference compared to control (p<0_05 ; 2-tailed t test).
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c-Jun were analyzed by Western blot with antibodies against phospho-c-Jun and
phospho-JNK (Figure II C). Acrolein at a concentration of 2.5 !J.M induced the protein
levels and phosphorylation of c-Jun compared with control (Figure liB). This induction
was highest at an acrolein concentration of 20 11M. We also noticed increased
phosphorylation of c-Jun, 2 h after treatment of cells with 20 11M acrolein (Figure II C).
The kinetics of c-Jun phosphorylation is similar to that of JNK. Thus, the use of specific
antibodies against phosphorylated JNK implicates the JNK signaling pathway in
electrophile-induced expression of Aldhlal gene.

Increased Aldhlal transcriptional activity by acrolein
To further confirm that the mechanism of Aldhlal transcription by acrolein or BHA
is mediated by AP-I, reporter gene assays using Aldhlal 5'-flanking sequence (-1963 to
+27 relative to the transcription start site) of Aldhlal gene was examined. This promoter
region of Aldhlal gene contains putative AP-l (-1516, -1069, -758 and -60) and Nrf2 (665, -1068 and -1753) binding sites, whose sequence closely resembles the canonical
TRE (TGACTCA) and ARE (TGACNNNGCA), respectively. We transfected HepG2
cells with Aldhlal luciferase construct (p2.0Aldhlal) that contains the proximal
promoter of Aldhlal gene cloned upstream of the luciferase gene. Twenty four hrs after
transfection, cells were treated with 20 !J.M acrolein for 6 hand luciferase activity was
examined and normalized to p-galactosidase activity (Figure 12). As control for
electrophile-induced transcription of ARE gene dependent on Nrf2, cells were transfected
with pGSTYa-ARELuc construct that contains the ARE of the GST-Ya gene cloned
upstream of a luciferase gene. We observed significant induction of Aldhlal promoter
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activity when cells were treated with acrolein (~1.8 fold) compared with untreated
control (Figure 12). However, the induction seen with the luciferase assay was modest
compared with the endogenous Aldh1a1 gene expression

(~4-fold)

in Hepa-1c1c7 cells

observed by qRT-PCR (Figure 8). This might be due to the fact that acrolein treatment in
the luciferase experiment was done in media containing low serum compared to serum
free media in the qRT-PCR experiment. Furthermore, luciferase experiments were
performed in HepG2 which might express higher endogenous levels of AP-1 compared to
Hepa-1c1c7. HepG2 cells were chosen for the transient transfection and luciferase
experiment due to high transfection efficiencies. However, as expected acrolein treatment
resulted in ~2.0 fold induction in the luciferase activity of GSTYa-ARE (Figure 12).
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Figure 12. The Aldh1a1 transcriptional activity is significantly increased by acrolein.
HepG2 cells were transfected with -1963/+27Aldh1a1 (p2.0Aldh1a1Luc) or GSTYaARE (positive control) luciferase plasmids for 24 h. After transfection, cells were treated
with either DMSO or 20 11M acrolein for 6 h and luciferase activity was examined. Data
are means ± SD from at least three independent experiments. *Significant induction
compared to vector transfected cells (p< 0.05; 2 tailed t test).
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Aldhlal transcriptional activity is not induced by Nrf2
To examine whether the acrolein-mediated induction

III

Aldh1a1 promoter

activity is dependent on Nrf2 transcription factor, we co-transfected cells with either
p2.0Aldh1a1Luc or GSTYa-ARELuc constructs and increasing concentration of Nrf2
expression plasmids (Figure 14). We confirmed over-expression of c-lun, lunD and Nrf2
in HepG2 cells by Western blot (Figure 13). We noticed a concentration-dependent
increase in ARE-driven transcriptional activity with Nrf2 over-expression compared with
vector control (Figure 14). However, the over-expression of Nrf2 failed to stimulate the
promoter activity of Aldh1al. The apparent lack of Nrf2-mediated Aldh1a1
transcriptional activity might be due to the absence of an electrophile or antioxidant
responsive element in the cloned region of Aldh1a1 proximal promoter. Thus, we
generated an Aldh1a1 luciferase construct containing 4.6 kb fragment of Aldh1a1
promoter. However, there was still no significant difference in the Nrf2-mediated
Aldh1a1 promoter luciferase activity compared to vector control when cells were
transfected with p4.6Aldh1a1 construct (Figure 14). Thus, transient transfection
experiments in HepG2 cells with Aldh1a1 5'-flanking luciferase reporter constructs
showed that co-transfection with Nrf2 expression plasmid alone or in the presence of tBHQ had no effect (data not shown) of Aldh1a1 transcriptional activity. In addition to
experiments with Nrf2-I- mice and SFN treatment in WT mice, this result further
confirmed that electrophile-induced expression of Aldhla1 is independent ofNrf2.
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Figure 13. Western blots indicating over-expression of c-Jun, JunD and Nrf2 in HepG2
cells. HepG2 cells in 6 well plates were transfected with 2

~g

ofpcDNA3 , c-Jun, JunD or

Nrf2 expression plasmid for 48 h. After transfection, cell extracts were separated on
SDS-PAGE gel and transferred onto nitrocellulose membranes. The membranes were
probed with antibodies against c-Jun (1 : 1000; sc-45) and JunD (1 : 1000; sc-74) and Nrf2
(1: 1000; C20, sc-722). Western blot experiment was performed in triplicate and the

figure is a representative blot.
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plasmids. Data are means ± SD from at least three independent experiments.
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induction compared to control vector-transfected cells (p< 0.05; 2 tailed t test).
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Increased Aldhlal transcriptional activity by AP-l
We assessed the effect of AP-l on Aldhlal transcriptional activity by transient
transfection experiments in HepG2 cells with Aldhlal 5'-flanking luciferase reporter
construct. Cells were co-transfected with either p2.0Aldhlal or pColTRE and with c-Jun,
c-fos or both c-Jun and c-fos expression plasmids. The pColTRE construct contains the
TRE sequence from human collagenase gene upstream of a luciferase gene and has been
used previously as a positive control for AP-l-dependent gene transcription. Overexpression of c-Jun resulted in :::::A-fold induction in Aldhlal transcriptional activity
(Figure 15). C-Jun over-expression was verified by Western blot (Figure 13). However,
we noticed that the regulation of Aldhlal promoter activity by c-Jun and c-fos was
different to that of the prototypic AP-l responsive gene, the human collagenase gene. As
shown in Figure 15, both c-Jun and c-fos are required for induction of collagenase TRE
luciferase activity. This synergism between c-Jun and c-fos for induction of collagenase
TRE activity was absent in Aldhlal gene, suggesting that c-JunlAP-l might induce
Aldhlal promoter activity as a homodimer and not as c-Junlc-Fos heterodimer.
To further test the hypothesis that electrophile-mediated transcription of Aldhlal is
dependent on AP-l and not the Nrf2 transcription factor, we assessed the role of c-Jun
dominant negative protein (TAM67) on acrolein-mediated Aldhlal transcription (Figure
16). HepG2 cells were co-transfected with p2.0Aldhlal and with c-Jun, TAM67 or both
c-JunlTAM67 expression plasmids. Twenty four hrs after transfection, cells were treated
for 6 h with 20 I-lM acrolein. Acrolein-mediated increase in Aldhlal promoter activity
was enhanced by over-expression of c-Jun. However, acrolein or c-Jun-induced
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Figure 15. The Aldhlal promoter activity is transactivated by c-Jun and c-Fos. HepG2
cells were transiently co-transfected with -1963/+27AldhlalLuc (p2.0AldhlalLuc),
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vector transfected cells (p< 0.05; 2 tailed t test).
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Figure 16. Inhibition of c-Jun mediated transactivation of Aldhl al-Iuciferase activity by
c-Jun dominant negative (TAM67) protein. HepG2 cells were transiently co-transfected
with -1963 /+27AldhlaILuc (p2.0AldhlaILuc) luciferase construct with c-Jun or TAM67
expression plasmid. 24 h after transfection, cells were treated for 6 h with DMSO or 20
/lM acrolein. Luciferase activity was normalized to
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activity. Data are

means ± SD from at least three independent experiments. *, significant difference
compared to vector-transfected cells (p< 0.05; 2 tailed t-test). &, significant difference
compared to acrolein-treated cells (p< 0.05; 2 tailed t test) # indicates significantly
different from c-Jun transfected and acrolein treated cells.
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transcription of Aldhlal was abrogated by over-expression of TAM67, supporting the
dependence on c-JunJAP-l.

The role of AP-l family proteins on Aldhlal transcriptional activity
We next examined the role of other AP-l family members on Aldhlal gene
transcription. Previous studies indicate that the jun family members (c-Jun, Jun D and lun
B) can induce the expression of genes as either homodimers or heterodimers with
members of the fos (c-fos, Fos B, Fra-l and Fra-2) family. We tested the effect of
increasing concentrations of c-lun, Jun D, lun B or Fra-l on Aldhlal transcriptional
activity in HepG2 cells. As shown in Figure 17, c-lun (;::,;3 fold), Jun D (;::,;2.5 fold) or lun
B (;::,;4.5 fold) at 80 ng concentration significantly transactivate Aldhlal promoter
luciferase activity compared to control. However, at lower concentrations (20 ng), only c-

lun showed significant induction of Aldhlalluciferase activity, suggesting increased
potency of the c-Jun transcription factor compared with the other Jun family members.
We next transfected Hepa-lclc7 cells with either pcDNA3.1 (control) or jun family (c-

lun, lunD or JunB) expression plasmids to assess whether over-expression of these
transcription factors can induce the protein levels of endogenous Aldhlal gene (Figure
18). Western blot analysis shows that over-expression of c-lun, JunD or JunB in Hepalc1c7 cells increased Aldhlal protein compared to vector control transfected cells.
These results further confirm that electrophile-mediated induction of Aldhlal is
dependent on AP-l genes.
We then assessed the role of the fos family (c-fos, Fra-l and Fra-2) on Aldhlal
transcriptional activity. The fos family are known to induce gene expression as
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Figure 17. Effect of lun family proteins on transactivation of Aldhlal -luciferase activity.
HepG2 cells were transiently co-transfected with -1963/+27AldhlaILuc
(p2.0AldhlaILuc) luciferase construct with increasing concentration (0, 20, 40 and 80
ng) of c-lun, lun D, lun B or Fra-l expression plasmid. Luciferase activity was
normalized to p-galactosidase activity. Data are means ± SD from at least three
independent experiments. * Significant induction compared to vector transfected cells
(P< 0.05 ; 2 tailed t test) .
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Western blot experiment was performed in triplicate and the figure is a representative
blot.
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Figure 19. The effect ofheterodimerization between c-jun and fos family proteins (c-fos,
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~-

galactosidase activity. The results are presented as fold induction compared to vector
control co-transfected cells. Data are means ± SD from at least three independent
experiments.

* Significant induction compared to vector transfected cells (p< 0.05; 2

tailed t test).

** Significantly different compared to c-Jun transfected cells (p< 0.05; 2

tailed t test).
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heterodimer with Jun family. While over-expression of Fra-1 or Fra-2 had no effect on
Aldh1a1 transcription either alone or with c-Jun, over-expression of c-fos inhibits c-Junmediated transactivation of Aldh1a1 promoter activity (Figure 19).
To further test the effect of c-fos on Aldh1a1 promoter activity, we transiently cotransfected HepG2 cells with either p2.0Aldh1a1 or pColTRELuc and with constant
amount of c-Jun or increasing concentrations of c-fos. While increasing concentrations of
c-fos resulted in a concentration-dependent increase in the transcriptional activity of
collagenase TRE, increasing concentrations of c-fos caused a concentration-dependent
decrease in Aldh1a1 promoter activity, which is suggestive of a dominant negative effect
of c-Fos on c-Jun-mediated transactivation of Aldh1a1 promoter activity (Figure 20).
These results indicated that transcriptional activation of Aldh1a1 promoter was mediated
by c-Jun homodimer and not by c-Junlc-Fos heterodimer. The preferred complex that
binds to Aldh1a1 promoter during acrolein-dependent transactivation of Aldh1a1 gene
appears to be c-Jun homodimer. Thus, over-expression of c-fos resulted in the formation
c-Junlc-fos heterodimer, thereby depleting the promoter of the active c-Jun homodimers.
Previous studies showed that Nrf2 can induce the expression of cytoprotective
genes by forming heterodimer with AP-1 proteins especially c-Jun (Lee and Murray,
2010). We examined whether there is cross-talk between c-Jun and Nrf2 in Aldh1a1
transcriptional activation. Cells were transfected with p2.0Aldh1a1 luciferase plasmids
with varying concentrations of c-Jun and Nrf2 (Figure 21). Luciferase activity
normalized to f3-galactosidase activity was assessed in these cells 48 h after transfection.
We observed that over-expression ofNrf2 had no effect on c-Jun-mediated
transactivation of Aldh1a1 promoter luciferase activity (Figure 21).
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Figure 20. Induction of Aldhlal transcription is mediated by c-Jun homodimer and not
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to p-galactosidase activity. The results are presented as fold induction compared to vector
control co-transfected cells. Data are means ± SD from at least three independent
experiments.

* Significant induction compared to vector transfected cells (p< 0.05; 2

tailed t test). # Significantly different from c-Jun transfected cells (p< 0.05; 2 tailed t
test).
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Figure 21. Lack of cross-talk between c-Jun and Nrf2 in transactivation of Aldhlal
promoter activity. HepG2 cells were transiently co-transfected with -1963/+27Aldhlal
luciferase construct with increasing concentrations of c-Jun and Nrf2 expression plasmid.
Luciferase activity was normalized to p-galactosidase activity and corrected for the
activities in cells co-tranfected with empty plasmids. Data are means ± SD from at least
three independent experiments.

* Significant induction compared to vector transfected

cells (p< 0.05; 2 tailed t test).
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Aldhlal transcription is not induced by NF-KB activation in HepG2
Previous studies indicate that electrophile-mediated transcription of
cytoprotective genes is also dependent on NF-KB activation (Karin, 1999;Lamb et aI.,
2003;Yang et aI., 2005). The NF-KB signaling pathway is highly sensitive to oxidative
and electrophilic stress. Electrophiles can induce the phosphorylation and degradation of
IKB, resulting in nuclear accumulation ofNF-KB. Moreover, the proximal promoter of
Aldhlal (-1963 to +27 relative to transcription start site) contains putative NF-KB
binding sites at positions -638 and -1139 relative to the transcription start site. We
assessed the effect of activation ofNF-KB by TNFa on Aldhlal transcriptional activity.
HepG2 cells were transfected with either p2.0Aldhlal or pNF-KB luciferase constructs
for 24 h. After transfection, cells'were treated with either 0.5ng/f.!1 or 1.0 ng/f.!l TNFa for
4 h (Figure 22a). As expected, we observed a concentration-dependent increase in NF-KB
responsive luciferase activity by TNFa. However, Aldhlal promoter activity was not
responsive to TNFa even at a concentration (1 ng/f.!l) known to activate NF-KB. This
indicates that the regulation of Aldhl al transcription by electrophiles is not directly
mediated by NF-KB. NF-KB proteins are also known to modulate gene expression by
forming active heterodimers with AP-l proteins (Rahmani et aI., 2001). We further
assessed whether there is cross-talk between the NF-KB signaling pathway and c-JunlAP-

1 on regulation of Aldhlal gene transcription. Cells were co-transfected with Aldhlal
luciferase plasmid and c-Jun expression plasmids. Cells were then treated with TNFa (1
ng/f.!l) for 4 h. The c-Jun mediated induction of Aldhlal promoter activity was
significantly reduced when cells were treated with TNFa. These results suggest that NFKB had little or no direct effect on
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Figure 22. Aldhlal promoter activity is not responsive to activation ofNF-KB signaling
pathway by TNFa. HepG2 cells were transfected with either 250 ng p2.0AldhlalLuc or
pNF-KBLuc in a 12 well plate. After overnight incubation cells were treated with
increasing concentrations ofTNFa as indicated for 4 h (A) or with 1 ng/I-.tl TNFa for 4 h
(B). Data are means ± SD from at least three independent experiments.

* Significant

induction compared to vector transfected cells (p< 0.05; 2 tailed t test). # indicates
significantly different from c-jun transfected cells (p< 0.05; 2 tailed t test).

88

Aldh1a1

promoter activity,

but it apparently alters

AP-1-dependent Aldh1a1

transcriptional activity in a yet to be defined manner.

Role of MAPKs in electrophile-mediated transcription of Aldhlal
The activities of AP-1 proteins are regulated by MAPK, such as p38, ERKl/2 and JNK.
The activation of JNK by oxidative stress or electrophile is known to phosphorylate its
downstream target c-Jun, resulting in increased transcriptional activity of c-Jun. We
examined the role ofMAPK in electrophile-mediated transcription of Aldhla1 gene.
HepG2 cells were co-transfected with -1963/+27Aldh1alluciferase construct and a cjun
expression plasmid. Cells were pre-treated with 0.4% DMSO, 25 f.lM SP600125 (JNK
inhibitor), 50 f.lM PD98059 (MEK inhibitor) or 40 nM OA (protein phosphatase 2a
inhibitor) for 17 h. Cells were then treated with either 0.4% DMSO or 20 f.lM for 6 h
(Figure 23). Acrolein-mediated increases in Aldhlal transcriptional activity were
diminished when cells were pretreated with JNK (SP600125) or MEK (PD98059)
inhibitors. The inhibition of the JNK signaling pathway also abrogated the c-Junmediated transactivation of Aldh1al promoter activity. However, pretreatment of cells
with the phosphatase 2A inhibitor, OA had a small but insignificant effect on acrolein- or
c-Jun-mediated transcriptional activation of Aldh1a1 gene. These results indicate that
JNK signaling pathway playa critical role in electrophile-mediated transcriptional
activation of Aldh1al gene.
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Figure 23. The role ofMAPKs in electrophile-mediated transactivation of Aldh1a1
promoter activity. Aldh1a1 transcriptional activity is significantly reduced by inhibition
of JNK (SP600125) and MEK (PD98059) kinase and increased by inhibition of protein
phosphatase 2A (Okadaic acid) activity in HepG2 cells. HepG2 cells were co-transfected
with p2.0Aldh1 a1 (-1963 /+27 Aldh1a1) luciferase construct and a c-jun expression
plasmid. Cells were treated with 0.4% DMSO, 50 /lM SP600125, 50 /lM PD98059 or 40
nM OA for 17 h. Data are means ± SD from at least three independent experiments.

Significant induction compared to vector transfected cells (p< 0.05; 2 tailed t test). #
indicates significantly different from c-jun transfected cells (p< 0.05; 2 tailed t test).
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DISCUSSION
The regulation of Aldhlal gene expression by BHA and acrolein

Reactive oxygen species are readily generated in the liver during normal
metabolism of foreign compounds and fatty acids, and even higher levels are produced in
pathological conditions, such as steatosis. The ROS-mediated destruction of membrane
lipids and free fatty acids results in the formation of lipid aldehydes by a chain AND
autocatalytic reaction known as lipid peroxidation. The reactive lipid-derived aldehydes
are most likely responsible for the pathophysiological effects ofROS and are implicated
in the pathogenesis of several oxidative stress-associated pathologies, such as
steatohepatitis, liver fibrosis, cancer and aging. Cells have developed elaborate systems to
cope with these toxic electrophiles, thereby preventing aldehyde-induced oxidative
damage. Our previous study to evaluate the sensitivity of cells with low expression of
Aldhlal indicate that lipid aldehydes, such as acrolein and HNE are readily detoxified by
Aldhlal (Makia et aI., 2011). Moreover, high levels of Aldhla 1 gene expression in the
liver and lens, two organs noted for generation of ROS and cytotoxic lipid aldehydes
suggest the importance of Aldhlal in cellular protection against oxidative stress-induced
damage. Thus, mechanisms to induce the expression of Aldhl al gene in mouse liver may
be a useful strategy to prevent oxidative stress-induced diseases, such as the progression
of hepatic steatosis to steatohepatitis.
Previous studies indicate that Aldhl al gene expression is induced by a variety of
microsomal enzyme inducers, such as phenobarbital (PB) and BHA (Alnouti and
Klaassen, 2008). Moreover, the expression of several genes encoding antioxidant and
electrophile detoxification enzymes, including Aldhlal was specifically elevated in
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mouse liver by electrophiles such as BHA and acrolein (Amunom, Makia and Prough,
unpublished report). The induction of Aldhlal and other electrophile detoxification
genes, such as Nqo-l, Ho-l and Gstml in mice liver by acrolein or BHA was confirmed
by qRT-PCR (Figure 7). Consistent with the mRNA levels, the cytosolic Aldh activity
was significantly induced in BHA or acrolein treated-mice liver, when 1 mM
propionaldehyde and NAD+ was used as substrate and cofactor, respectively (Figure 9),
to measure Aldhlal-specific enzyme activation. Enzyme kinetic studies with
recombinant mouse Aldhs (Table 1) indicate that propionaldehyde is a good substrate for
Aldhlal and that Aldhlal solely uses NAD+ as cofactor. Furthermore, the expression of
cytosolic Aldh3al is negligible, while Aldhlal is highly expressed in normal mice liver,
suggesting that the predominant cytosolic isoform of Aldh induced in mice liver by BHA
or acrolein is Aldhlal. Thus, cytosolic Aldhlal activity is induced in mice liver by
acrolein or BHA compared to control mice.
h. The role of Nrf2 in electrophile-mediated activation of Aldhlal gene expression
The signaling pathway involved in electrophile-mediated transactivation of
Aldhl al gene in mice liver is not clearly understood. However, BHA and acrolein are

known to stimulate the expression of cytoprotective genes by direct activation of redoxresponsive transcription factors or by indirect activation of protein kinase signaling
pathway, such as MAPK. To assess the role ofNrf2 in electrophile-mediated
transcription of Aldhl al gene, we fed C57BL6 WT or Nrf2-I- mice diet containing BHA
for 7 days and analyzed the mRNA expression of Aldhlal and Nrf2-target genes, Nqol,
Ho-l and Gstml by qRT-PCR (Table 2). BHA-induced expression ofNqol, Ho-l and
Gstml genes in WT mice were significantly reduced in Nrf2-I- mice, implicating Nrf2 in
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BHA-induced expression of these genes. However, the fold-induction of Aldhlal mRNA
expression by BHA in WT mice was not significantly different from Nrf2-I - mice,
indicating that BHA-mediated transcription of Aldhlal gene is not dependent on Nrf2.
Furthermore, we demonstrated that the prototypic Nrf2 activator, SFN did not induce
Aldhlal gene expression in mouse liver (Figures 7 and 9). These results were consistent
with previous studies using keap I-knockdown (keap l-kd) mice with constitutively active
Nrf2 in the liver (Reisman et aI., 2009). The mRNA levels ofNqol and Gstml genes
were significantly increased in keap l-kd mice compared to WT control, suggesting that
over-expression ofNrf2 transcriptionally activates these genes. However, Aldhla1
mRNA expression in the livers ofkeapl-kd mice was comparable to that ofWT mice,
supporting the hypothesis that the induction of Aldhlal gene expression by electrophiles
is regulated by Nrf2-independent mechanism.
The molecular mechanism underlying transcriptional regulation of Aldhlal gene
by electrophiles was further examined by analysis of the 8.0 kb region of the 5' -flanking
sequence ofthe mouse Aldh1a1 gene for AP-l-like (TRE) and Nrf2-like (ARE) binding
sites using the Genomatrix MatInspector Professional consensus sequence identification
program. The region between -1963 to +27 bp relative to the transcription start site
containing AP-l-like (-1516, -1069, -758 and -60) and Nrf2-like (-665, -1068 and -1753)
binding sites was cloned upstream of the luciferase reporter plasmid. Transient
transfection experiments in HepG2 demonstrate that Aldhlal-luciferase reporter
containing these cis-regulatory elements is responsive to acrolein (Figure 11). Acrolein
induced an approximately 1.8-fold increase in Aldhlal-luciferase activity, demonstrating
that -1963 to +27 region of Aldh1al promoter is responsive to electrophiles.
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Electrophiles promote nuclear accumulation ofNrf2 by causing its dissociation from
keap 1. Nrf2 then binds to an ARE in the promoter of target gene resulting in increased
gene expression (Nguyen et aI., 2004;Nguyen et aI., 2009;Rushmore et aI., 1991). While
there was a concentration-dependent activation of GSTYa-ARE-Iuciferase activity by
Nrf2, increasing concentrations ofNrf2 failed to stimulate the activity of Aldhlalluciferase reporter (Figure 14). A possible explanation for the lack of responsiveness to
Nrf2 of Aldhl al-Iuciferase reporter could be due to the absence of a functional ARE in
the region (-1963 to +27 bp) of Aldhlal promoter used for our experiments. In addition,
Aldhlal-luciferase construct containing 4.6 bp region of Aldhlal promoter was also
unresponsive to Nrf2, which further lends support to our hypothesis that electrophileinduced expression of Aldhlal gene is independent ofNrf2.

The role of AP-l in BHA or acrolein-mediated activation of Aldhlal gene
We hypothesized that electrophile-induced transcription of Aldhlal gene is
mediated by activation of AP-l transcription factor. The induction of antioxidant and
electrophile detoxification genes by electrophiles is known to be mediated by stimulation
of the expression and activity of AP-l genes. For example, oxidative stress-induced
expression of human ferritin H gene was dependent on activation of lunD (Tsuji, 2005).
Expression c-jun and c-fos genes were significantly increased by BHA or acrolein in the
liver of WT mice (Figure 10 and 11). While the mRNA expression of c-fos in the liver of
WT mice by BHA or acrolein compared to control were similar (;:::2-fold), we observed a
4-fold increase in c-jun mRNA expression by acrolein and a 2-fold increase by BHA. The
mRNA levels of c-jun and c-fos gene were also significantly increased by acrolein in
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Hepa-lc1c7 cells compared to untreated cells. The basal expression of c-jun or c-fos
genes were significantly reduced in Nrf2-I- mice compared to WT control. Moreover, the
induction of c-jun and c-fos gene by BHA in WT mice was reduced in Nrf2-I- mice,
suggesting that the Nrf2 modulates the basal and BHA-induced expression of the AP-l
genes. Previous studies in Nrf2-I - mouse embryonic fibroblast (MEF) also reported the
regulation of AP-l gene expressions by Nrf2 (Yang et aI., 2005). Thus, the low basal
expression of c-Jun and c-fos possibly explained the reduced expression of Aldhlal gene
observed in the liver of Nrf2-I - mice not treated with BHA. The phenolic electrophilic
compounds, such as BHA have been reported to augment the protein expression and
activity of AP-l genes (Choi and Moore, 1993;Li et aI., 2005;Tsuji, 2005;Yang et aI.,
2002). The transactivation potential of c-Jun is enhanced by N-terminal phosphorylation
through JNK (Eferl and Wagner, 2003). WT mice treated with BHA showed increased
protein expression and phosphorylation of c-Jun compared to control (Figure 10). We
also observed increased phosphorylation of c-Jun, 2 h after treatment ofHepalc1c7 cells
with acrolein (20 11M) (Figure 11). The phosphorylation of c-Jun, 2 h after treatment
correlates with the activation of its upstream kinase JNK. These results suggest that
electrophile-induced transcription of Aldhlal gene is mediated by enhanced expression
and activity of AP-l genes.
Co-transfection of HepG2 cells with collagenase TRE-Iuciferase reporter
constructs and c-Jun, c-fos or c-Jun/c-fos expression plasmids demonstrate that both cJun and c-Fos were required to activate the collagenase TRE-Iuciferase activity (Figure
15 and 20). However, c-Jun strongly activated (4-fold) Aldhlal-luciferase reporter,
while co-transfection with plasmids encoding c-Fos abrogated reporter activity,
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suggesting that c-Jun activates Aldhlal transcriptional activity as a homodimer and
collagenase TRE as heterodimer with c-Fos. Transient transfection analysis with c-Jun
dominant negative proteins (TAM67) further confirmed that activation of Aldhlalluciferase reporter activity by acrolein is dependent on c-Jun (Figure 16).
Transient transfection experiments by co-transfection of Aldhlal 5'-flanking
luciferase constructs and c-Jun, JunD or JunB expression plasmids in HepG2
demonstrates that many members of the jun family proteins activate Aldhlal-luciferase
activity, with c-Jun serving as a more effective transcription factor (Figure 17). We also
noticed that while Fral and Fra2 had no significant effect on c-Jun-mediated
transactivation of Aldhlal-luciferase activity, over-expression of c-Fos modestly
inhibited activation of Aldhlal reporter activity by c-Jun (Figure 19). Abrogation of cJun-dependent gene activation by c-Fos was previously reported by Marden et aI, who
demonstrated that whereas c-Jun homodimers strongly activated CYP2J2 expression,
heterodimers formed between c-Fos and c-Jun were not active (Marden et aI., 2003).
Moreover, previous studies also demonstrated that the c-Jun-mediated activation of the
human atrial natriuretic peptide (ANP) promoter was inhibited by overexpression of cFos (Kovacic-Milivojevic and Gardner, 1992).
The effects of increasing concentrations of c-Fos on the activation of Aldhl al- or
human collagenase TRE-Iuciferase activity by c-Jun was used to further assess the role of
c-Fos on c-Jun-mediated transactivation of Aldhlal gene (Figure 19). A concentrationdependent activation and inhibition of collagenase TRE- and Aldhlal-luciferase activity,
respectively, by c-Fos was noted, indicating that the predominant AP-l complex that
causes enhanced Aldhlal promoter luciferase activity is c-Jun homodimer and not c-

96

Jun/c-Fos heterodimer. Thus, the mouse Aldhl al and human CYP2J2 genes show similar
pattern of regulation by AP-l.

The role of NF-KB signaling pathways in BHA or acrolein-mediated activation of
Aldhlal gene

Previous studies demonstrate that c-Jun can enhance transcription of target gene
by functional interaction with other transcription factors, such as Nrf2 and NF-KB. The
up-regulation of human CYP2J2 gene by BHA was shown to be mediated by interaction
ofc-Jun with Nrf2 (Lee and Murray, 2010). Thus, Nrf2 apparently acts as a binding
partner for c-Jun transcriptional activation of CYP2J2 gene. However, transient
transfection experiment establishes that over-expression ofNrf2 had no effect on c-Junmediated activation of Aldh1a1-luciferase activity (Figure 21). Acrolein and other
electrophiles have been reported to enhance the expression of cytoprotective genes by
activation of nuclear factor KB (NF-KB) transcription factor (Pinkus et aI., 1996).
Moreover, AP-1 interacts with NF-KB to activate gene transcription (Rahmani et aI.,
2001). TNFa is a pro-inflammatory cytokines activated by cytotoxic aldehydes and is a
strong activator of the NF-KB signaling pathway. The concentration (1 ng/ul) ofTNFa
that normally stimulate the NF -KB responsive luciferase activity could not activate
Aldhlal-Iuciferase activity (Figure 22). However, TNFa inhibited c-Jun-mediated
activation of Aldhlal-Iuciferase activity, suggesting that NF-KB activation abrogates cJun induced activation Aldhlal activity.
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Role of MAPKs in electrophile-mediated transcription of Aldhlal
Lipid aldehydes were previously shown to induce the expression of electrophile
detoxifying genes by activation ofMAPK such as JNK and ERK (Lamb et al., 2003;Wu
et al., 2006). Hepalc1c7 cells treated with acrolein (20 MM) showed increase JNK
phosphorylation 2 h after treatment compared to untreated control (Figure 10).
Experiments using specific inhibitors of JNK, ERK or MEKI revealed the functional
importance ofMAPK activation for Aldhlal gene expression. The treatment of HepG2
with JNK (SP600125) or ERKlMEKl (PD98059) inhibitors blocks acrolein or c-Junmediated transactivation of Aldhlal promoter activity (Figure 22). However, the
phosphatase 2A inhibitor (okadaic acid) had no significant effect on acrolein or c-Junmediated transactivation of Aldhlalluciferase activity. These results suggest that JNK
plays a critical role in electrophile-induced transcription of Aldhlal and shows functional
consequences of increased phosphorylation of c-Jun and JNK by acrolein.
In summary, we have provided evidence that Aldhlal gene expression can be
induced by electrophiles such as acrolein and BHA and that increased expression of
Aldhlal gene by electrophiles is dependent on c-JuniAP-l and not Nrf2 or NF-KB.
Aldhlal gene expression was modulated by a c-Jun homodimer, but not by c-Junlc-fos
heterodimers. The MAPK especially JNK also plays a crucial role in electrophilemediated transactivation of Aldhlal gene.
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CHAPTER IV
CHARACTERIZATION OF CIS-RESPONSIVE DNA ELEMENT INVOLVED IN
REDOX-PROTECTIVE TRANSCRIPTION OF ALDHIAI GENE

INTRODUCTION
The comparison of the sequences of the proximal promoter region of mouse
Aldhlal (m-AHD-2) revealed similarities with the rat RALDHIAI and the human
hALDHIAI (Guimond et aI., 2002;Hsu et aI., 1999). Analysis ofthe 5'-flanking region
of the mouse Aldhlal for putative regulatory elements revealed an Oct 1 binding site at68 bp and a CCAAT box at -87 bp relative to the transcription start site, which are well
conserved in the rat RALDHI and human ALDHI genes. Transient transfection studies
using rat RALDHI promoter deletion luciferase reporter constructs demonstrated that
CCAAT and Oct motifs were essential for basal promoter activity (Guimond et aI., 2002).
The conservation of these motifs in the mouse Aldhlal and human ALDHIAI promoter
suggests that these regulatory elements might also be critical for the basal promoter
activity of mouse Aldhlal and human ALDHIAl. The analysis of nucleotide sequence
of the mouse Aldhlal promoter region, starting from -1963 to +25 relative to the
transcription start site revealed a number of potential regulatory elements, such as GAT A,
E2F, AhR-Arnt, Stat5, Sox5, SPI and NF-KB binding sites. Previous studies identified a
putative retinoic acid response element (RARE) located at -91/-75 bp adjacent to the
CCAAT box of the hALDHI gene (Elizondo et aI., 2000;Elizondo et aI., 2009). The
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RARE sequence was later identified at a similar position in mouse Aldhl promoter and
was reported to mediate retinoic acid (RA) down-regulation ofhALDHl and mouse
Aldhlal gene expression through interaction of the RAR and

C/EBP~

in human (HepG2)

and mouse (Hepal) hepatoma-derived cells (Elizondo et aI., 2009), respectively. The
down-regulation of ALDHlAl by elevated hepatic RA is a feedback pathway to control
RA biosynthesis since ALDHlAl is a major enzyme involved in the biosynthesis ofRA.
Aldhlal is highly expressed in the liver and lens which are suggested to generate
large amounts of ROS and cytotoxic lipid aldehydes, such as HNE and acrolein
(Marchitti et aI., 2008;Vasiliou et aI., 2004). It is postulated that increased expression of
Aldhlal in these organs is a mechanism to protect against aldehyde-induced oxidative
damage and oxidative stress-induced pathologies. We also showed that Aldhlal
efficiently metabolizes lipid-derived aldehydes and protects liver-derived cell lines from
the toxic effect oflipid aldehydes. The induction of Aldhlal gene expression by high
levels of acrolein might represent a mechanism to control the levels of acrolein in the
body by enhanced metabolism and detoxification. Thus, an understanding of the factors
controlling Aldhl al expression may assist efforts to control the progression of steatosis
to steatohepatitis.
We demonstrated that electrophiles, such as BHA and acrolein induce the
expression of Aldhlal gene by activation of c-juniAP-l proteins. However, it is still not
clear how AP-l modulate Aldhl al gene expression by electrophiles. The regulation of

Aldhl al gene expression by AP-l is similar to that of Cyp2J2 gene but different from the
human collagenase gene. The AP-l proteins are composed of either homodimers of fun
family (c-Jun, JunD and JunB) or heterodimers with/os family (c-fos, Fos-B, Fral and
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Fra2). One ofthe well-characterized AP-1 target genes is the human collagenase gene,
which contains a consensus TRE (TGAC/GTCA). Tumor-promoting phorbol12myristate 13-acetate (TPA) was shown to activate the transcription of human collagenase
gene by promoting the association of c-Jun/c-Fos heterodimer to its cognate TRE. The
AP-1 (c-jun/c-fos) transcription factors are also known to recognize the half site
(underlined) of the ARE (AlGTGACNNNGC) and are activated during oxidative stress
and by electrophiles. Hasselblatt et al demonstrate that c-Jun binds to the nos2 promoter
in vivo and is required for efficient expression of inducible nos gene during Con A- or

LPS-mediated hepatitis (Hasselblatt et a1., 2007). Moreover, a previous study in HepG2
cells demonstrates that the up-regulation of CYP 2J2 gene transcription by BHA was
dependent on the binding of c-Jun and Nrf2 to an atypical AP-1-like element in the
proximal promoter of CYP2J2 (Lee and Murray, 2010). Ethanol was shown to induce the
expression of the TFIIIB components, Brfl and TATA-binding protein (TBP) by
promoting a marked increase in the direct recruitment of c-Jun to TBP and Brfl (Zhong
et a1., 2011). Therefore, we hypothesized that electrophiles induce the expression of
Aldh1a1 gene by promoting the binding of c-Jun to its cognate cis-acting regulatory
elements in the promoter of Aldh1a1 gene.
Analysis of the 5'-flanking region of the mouse Aldh1a1 gene using the
Genomatrix MatInspector Professional consensus sequence identification program
indicates the presence of four AP-1-like elements at positions -1516 (GCTGAATCA), 1069 (GCTCAGTCA), -758 (ATGATTCA) and -60 (ATGACCCT). Luciferase reporter
constructs containing Aldh1a1 promoter region with these AP-1-like binding sites were
shown to be responsive to c-Jun homodimers and not c-Jun/c-fos heterodimers. A
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number of AP-l-responsive genes contain atypical AP-l-like elements that accommodate
alternate combination of bZIP factors and this can explain the difference in the
modulation of Aldhlal and collagenase gene expression by AP-l transcription factors.

In this chapter, we characterized the cis-regulatory DNA element involved in
redox-protective transcription of Aldhlal gene. Furthermore, we assessed in vivo whether
BHA exposure promotes the binding of c-JunlAP-l to the putative AP-l-like binding
sites in the proximal promoter of mouse Aldhl al gene.

EXPERIMENTAL DESIGN AND METHODS
Cloning of Aldhlal deletion plasmids.
Mouse genomic DNA was purchased from Promega (Madison, WI) and used in
PCR experiments to generate 2002 bp of mouse 5'-flanking sequence as described above
in Chapter 3. This region contains -1963/+23 bp relative to the transcription start site
(TSS) of mouse Aldhlal gene. We generated three (3) deletion constructs; 1534 bp (1496/+27), 1043 bp (-1005/+27) and 518 bp (-480/+27) fragments of the mouse Aldhlal
promoter by PCR using the -1963/+23 bp as template. The downstream primer for
synthesis of the three deletion constructs was similar to that of the 2002 bp fragment
(Chapter 3). The following upstream primers, which introduced a Nhel site, were used to
generate the PCR products for the deletion constructs.
1534 bp:

5' -GCT AGCCA TGGA TCTGGCTGGATCTG-3.

1043 bp:

5'-GCTAGCGGAGGTGGCAATTTCACTAC-3'.

518 bp:

5'-GCTAGCGGTTTGCTGGTAGCCATGTT-3'.
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The PCR products were recovered into a pCR2.1 vector (Invitrogen, Carlsbad CA). The
sequences of the PCR products were confirmed by sequence analysis in the University of
Louisville, Center for Genetics and Molecular Medicine Nucleic Acid core facility. Nhel
and HindIII were used to subclone the 1534bp, 1043bp, and 518bp Aldhlal promoter
fragments into pGL3-Basic to generate -14961+27Aldhlal-Luc, -1 005/+27Aldhl al-Luc
and -4801+27Aldhlal-Luc constructs, respectively. A far upstream region of the
Aldhlal promoter (-4673/-3000 bp) that contains putative ARE/TRE site was also
generated using the upstream primer; 5'-GGTACCACTCAAATGGCTGAGCCAATG3' and downstream primer, 5'-GCTAGCACTCTTCCCATGGCTGTCTTG-3'. This 1684
bp PCR fragment was cloned upstream of the -1496/+27Aldhlal or -518/+27AldhlalLuc to generate the heterologous mouse Aldhlal constructs pGL1.5-1684Aldhlal and
pGLO.5-1684Aldhl aI, respectively.
HepG2 cells were transfected using 1 Ilg/2.5 ilL of Lipofectamine LTX and 1 ilL
of Plus (Invitrogen, Carlsbad, CA) with 250 ng/well ofpGLO.5-1684Aldhlal, pGL1.51684Aldhlal, -1963/+27Aldhlal, -14961+27Aldhlal-Luc, -1005/+27Aldhlal-Luc and-

4801+27 Aldh 1al-Luc. The cells were co-transfected with or without pRSV -cjun (50 ng).
After overnight incubation at 37°C, the transfection media was replaced with 1 ml media
containing 10% FBS. The cells were harvested after overnight incubation (;::::17-24 h) with
100 ilL of Luciferase cell lysis buffer (Promega, Madison, WI). The p-galactosidase and
luciferase activities were determined as described by Falkner et al (1998). The data were
expressed as luciferase activity relative to p-galactosidase activity to normalize for
transfection efficiency. All transient transfection experiments were performed in triplicate
and experiments were repeated at least twice for confirmation. Statistical comparisons
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among treatment groups were determined using a two-tailed t test, with p<0.05 as a
criterion for significance.

Site-Directed Mutagenesis
Mutagenesis of the two putative AP-1 sites located at -1069 and -757 bp of
Aldh1a1 was carried out using GeneTailorTm Site-Directed Mutagenesis systems
(Invitrogen, Carlsbad, CA) following standard protocol. Briefly, the -1496/+27Aldh1a1
construct was methylated using DNA methylase at 37°C for 1 h. The template strand is
methylated so that it is marked for degradation by the host McrBC endonuclease. The
methylated plasmid was then amplified by PCR with two overlapping primers, one of
which contains the target mutation using Platinum Taq Polymerase High fidelity. The
PCR conditions were as follows: 94°C for 2 min; 20 cycles of 94°C for 30s; 55°C for
30s; 68°C for 7 min (;:::; 6.5 kb plasmid); and 68°C for 10 min. The primers for
mutagenesis of AP-1 sites located at -1069 and -758 bp are shown below.
-758 bp: Sense, 5'-TCGACACTGCTTAGAGTAATaATaaACAAGTGCACGC-3'
Antisense, 5' ATTACTCTAAGCAGTGTCGAAGGAAAGAAT -3'
-1069 bp: Sense, 5'-TATTTACAAATTGAGAAGCTaAaTaAAGGCAAAAAGA-3'
Antisense, 5'-AGCTTCTCAATTTGTAAATACAGAGAGGAA-3'
The PCR product, linear and double-stranded was analyzed by a 1% agarose gel stained
with ethidium bromide. The mutagenesis mixture was then transformed into One-ShotR
MAX Efficiency DH5a™-Tl R E. coli. The host E. coli circularized the linear mutated
DNA and McrBC endonuclease in the host cell then digested the methylated template
DNA, leaving only the unmethylated and mutated product. The sequences of the
recovered PCR products were analyzed for mutagenesis by sequence analysis in the
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University of Louisville, Center for Genetics and Molecular Medicine Nucleic Acid core
facility.

Preparation of Nuclear Extracts
Nuclear extracts were prepared from mouse liver and HepG2 cells transfected
with either pcDNA3.1 (vector control; 2 Ilg/well) or pcDNA3.1-c-Jun (c-Jun expression
plasmid; 2 Ilg/well) for 48 h using NE-PER nuclear and cytoplasmic extraction reagents
(Pierce, Rockford, IL) according to standard protocol. Briefly, HepG2 cells (1 x 106) in
35 mm dishes were washed twice with ice-cold PBS and then scraped from the dishes
with 1 ml of PBS and transferred to micro centrifuge tubes. Cells were then centrifuged at
1500g for 5 min. The supernatant was discarded and the cell pellet was allowed to swell
after addition of ice-cold CERI with vigorous vortexing of the tube to suspend the cell
pellet. After 10 min of incubation at 4°C, ice-cold CERII was added and the tube was
again vigorously vortexed and incubated for 1 min. The tube was then centrifuged at
16000 x g for 5 min and the cytoplasmic fraction was transferred to a clean tube. The
insoluble nuclear pellet was suspended in ice-cold NER. The tube was then incubated in
ice for 40 min with 15s vortexing every 10 min. The tube was then centrifuged at 16000 g
for 10 min and the nuclear extract was aliquoted and stored at -80°C until used for
EMSA. Protein concentration was determined by Pierce® BCA Protein Assay (Pierce,
Rockford, IL) using bovine serum albumin as standards.

Electrophoretic Mobility Shift Assay (EMSA)
A non-radioactive LightShift Chemiluminescent EMSA kit (Pierce, Rockford, IL)
was used to examine whether c-Jun binds to the putative AP-l binding sites on Aldhlal
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proximal promoter. The oligonucleotides used as probes or competitors in gel shift assays
were end-labeled at their 5' with biotin and the sequences are shown below:
AP-l Consensus:

AP-l Site B:

Sense,

5'-CTAGTGATGAGTCAGCCGGATC-3'

Antisense,

5' -GATCGATCCGGCTGACTCATCA-3'

Sense,

5:- TGCTTAGAGTAATGATTCACAAGTGCACG-3'

Antisense,

5' -CGTGCACTTGTGAATCATTACTCT AAGCA-3'

AP-l Site B Mut: Sense,

AP-l Site C:

5'-TGCTTAGAGTAATaATaaACAAGTGCACG-3'

Antisense,

5'-CGTGCACTTGTttATtATTACTCTAAGCA-3'

Sense,

5' - AATTGAGAAGCTCAGTCAAGGCAAAAAGA-3'

Antisense,

5'-TCTTTTTGCCTTGACTGAGCTTCTCAATT-3'

AP-l Site C Mut: Sense,
Antisense,

5' -AATTGAGAAGCTaAaTaAAGGCAAAAAGA-3'
5'-TCTTTTTGCCTTtAtTtAGCTTCTCAATT-3'

The complementary oligonucleotides were annealed using a thermocycler (Applied
Biosystems, GeneAmp PCR system 2400) program for annealing complementary
oligonucleotides. EMSA reactions containing 20 fmoles of biotin-end labeled doublestranded probes and 5 Ilg nuclear proteins (NP) were incubated for 20 min at room
temperature in a lOX binding buffer with 5 mM MgCh, 2.5 % glycerol, 1% NP-40 and
50 ng/1l1 poly (dI-dC). The specificity of binding was analyzed by excess of unlabeled
double stranded probes included in the binding reactions. In the competition experiments,
25- to lOO-fold excess of unlabeled double stranded EMSA probes was included in the
binding reactions. To further confirm specificity of binding, a 100-fold excess of
unlabeled double stranded probe with mutations at the AP-l binding site was included in
the binding reactions. For super shift analysis, nuclear extracts were incubated with
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rabbit polyclonal c-Jun (sc-44 X, Santa Cruz Biotechnology, CA), c-fos (sc-52 X) or Nrf2
(sc-722) antibodies for 30 min at 4°C before addition of the labeled probe. Loading
buffer was added to the reactions and the protein-DNA complexes were resolved by
electrophoresis on 6% precast DNA retardation gel (Invitrogen) in 0.5% TBE buffer (90
mM Tris-HCI, 90 mM boric acid, 2.5 mM EDTA) at 100 V for 1 h at 4°C. Following
electrophoresis, the binding reactions was then electrophoretically transferred onto a
nylon membrane (Amersham Hybond-N+, GE Healthcare) with 0.5% TBE for 1 hat
100V. At the end of transfer, the transferred DNA-protein complexes were then crosslinked onto membrane using a UV cross-linker that was set at 120 mJ/cm2 for an
exposure time of2 min. The biotin-labeled DNA was then detected using the
Chemiluminescent Nucleic acid detection module (Pierce) following standard procedure
for detection of immobilized nucleic acids.

Chromatin Immnnoprecipitation Assay (ChIP).
C57BLl6 mice were placed on AIN76 diet (control) or diet containing 0.45%
BHA for 7 days. Animals were sacrificed and intact nuclei from the livers of control or
BHA-treated mice were purified by sucrose density gradient without disrupting the
internal macromolecular interactions. The ChIP assay was performed using the MAGnify
chromatin-immunoprecipitation system (Invitrogen, CA) according to manufacturer's
protocol with minor modifications. The pure nuclei were suspended in PBS and fixed in
1% formaldehyde in PBS at room temperature to cross-link the DNA binding proteins to
cognate cis-acting elements. The nuclei were harvested after 30 min, washed with PBS
and solubilized in Buffer A containing 50 mM Tris-CI, pH 8.0, 1% SDS, 5 mM EDTA, 5
mM EGTA, 0.5 mM PMSF and complete protease inhibitor mix (Roche Molecular
107

Biochemicals). The homogenate was sonicated 6-7 times on ice at 40% setting (Branson
sonicator) to shear the chromosomal DNA into fragments of ~200 to 500 bp in size. The
insoluble material was removed by centrifugation at 20,000 x g at 4°C for 5 min and the
soluble chromatin supernatant (chromatin extract) was stored at -80°C until use. Before
use, the chromatin extract was diluted 5-fold with dilution buffer containing 20 mM TrisCI, pH 8.0, 1% Triton X-IOO, 1.2 mM EDTA and 150 mM NaCl. The cross-linked
protein-DNA fragments were immunoprecipitated by overnight incubation of diluted
chromatin with antibodies against IgG (control), c-Jun (sc-44 X; 1 Ilg/Ill) or c-fos (sc-447
X; 1 Ilg/Ill) conjugated to Dynabeads protein A/G. The immune complexes were washed
sequentially with IP buffer 1 and 2, and the protein-DNA cross-links were reversed by
heat treatment in reverse cross-linking buffer containing proteinase K. The uncrosslinked
DNA pulled down by the different antibodies was purified using the DNA purification
magnetic beads. The purified DNA was analyzed by real-time PCR (ABI 7900HT
Sequence Detector System, Applied Biosystems, Foster City, CA) with primers spanning
the putative AP-l sites Band C in the proximal promoter of Aldhial gene. The
sequences of the ChIP primers are shown below:
AP-I Site B: Forward,

5'-GTT CCT TCC ATA TCT TGT GCT GGG-3'

Reverse,

5'-GAG GTG CGT GCA CTT GTG AAT CAT-3'

AP-I Site C: Forward

5'-TCC TTC AAG GTC TGT GAC CAA AGC-3'

Reverse

5'-AAC AGG GAC CTG AGG AGT GTG TTT-3'
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RESULTS
Identification of AP-l-like elements that mediate electrophile response in the
proximal promoter of Ald"l al gene by deletion analysis
The analysis of the proximal promoter of Aldhlal by the Genomatrix
Matlnspector Professional software revealed four putative AP-l-like elements at
positions -1516, -1069, -758 and -60 (Figure 24). The p2.0Aldhlal construct containing1963 to +27 of Aldhlal proximal promoter was used as template for the generation of
three deletion constructs: p1.5Aldhlal (-1496 to +27), pl.OAldhlal (-1005 to +27) and
pO.5Aldhlal (-480 to +27) with progressive loss of the AP-1-like elements. To identify
the critical AP-1-responsive element required for transactivation of Aldh 1a 1 gene by cJun, HepG2 cells were co-transfected with the Aldhla1 5'-flank luciferase reporter
constructs containing progressive deletions ofthe AP-l-like elements and a plasmid
encoding c-Jun protein. The deletion of the AP-l-like element at positions -1516 had no
significant effect on c-Jun-mediated transactivation of Aldhlal-luciferase activity (Figure
25). However, the deletion of the putative AP-l sites at positions -1069 and -758
significantly decreased activation of Aldhlal-luciferase activity by c-Jun. Thus, deletion
analysis indicates that the region containing these two AP-l-like elements at positions 758 (AP-l site B) and -1069 (AP-l site C) relative to Aldhlal transcription start site is
critically important for c-Jun-dependent transactivation of Aldhlal transcriptional
activity.
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Figure 24. The nucleotide sequence of mouse Aldhlal promoter depicting potential AP1, Nrfl (ARE) and NF-KB binding sites as well as other putative transcription factor (TF)
binding sites. The sequence shown is -1963 to +27 bp of mouse Aldhl al promoter. The
underlined nucleotides represent putative TF binding sites identified by Genomatrix
Matlnspector Professional consensus sequence identification software. Arrow indicates
the transcription start site (+ 1).
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Figure 25 . Deletion analysis to identify the AP-l-like responsive element in the proximal
promoter Aldhlal gene. HepG2 cells were transiently co-transfected with 250 ng of4673/+27Aldhlal , -1963/+27Aldhlal, -14961+27Aldhlal , -10051+27Aldhlal or4801+27Aldhlalluciferase construct and either pcDNA3.1 vector control or c-Jun (40
ng) expression plasmid. Luciferase activity was normalized to p-galactosidase activity
and corrected for activities in cells co-transfected with empty plasmids. Data are means ±
SD from at least three independent experiments.
vector transfected cells (p< 0.05; 2 tailed t test).
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* Significant induction compared to

Characterization of AP-l-like elements responsible for c-Jun-mediated
transactivation of Aldhlal promoter activity by mutagenesis analysis
To investigate the importance of the AP-1-like elements at -1069 and -758 in the
activation of Aldh1a1-luciferase by c-Jun, these putative AP-1 elements were mutated by
site directed mutagenesis. The functional consequences of the mutations were examined
by transient transfection of the WT and mutant Aldh1a1-luciferase reporter constructs
into HepG2 cells. The mutation of the proximal putative AP-1 element at position -758
(p1.5Aldh1a1MutB) resulted in ::::c50% reduction in c-Jun-mediated activation of Aldh1a1
promoter activity compared to the pl.5Aldh1a1 WT (WT) constructs (Figure 26).
However, mutation of the distal AP-I sequence at position -1069 (p1.5Aldh1aIMutC)
modestly decreased Aldh1a1-luciferase activity compared to the WT plasmid. Double
mutation of the putative AP-1 elements at sites Band C in the promoter of Aldhla1 gene
attenuated c-Jun responsiveness. These results indicate that both AP-1-like elements at
sites Band C may be essential for c-Jun dependent transactivation of Aldh1a1 gene with
the AP-1 at site B playing a pivotal role.
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Figure 26. Mutagenesis of the putative AP-1-like elements located at -1069 bp (C site)
and -758 bp (B site) on Aldh1a1 promoter activity. HepG2 cells were transiently cotransfected with 250 ng ofp1.5Aldh1a1 WT (-1496/+27 Aldh1a1), p1.5Aldh1a1MutB,
p1.5Aldh1a1MutC or p1.5Aldh1a1MutB/C luciferase constructs and either pcDNA3.l or
c-Jun (40 ng) expression plasmids. Luciferase activity was normalized to p-galactosidase
activity and corrected for activities in cells co-transfected with empty plasmids. Data are
means ± SD from at least three independent experiments.

* Significant difference

compared to c-Jun and p1.5AldhWT co-transfected cells (p< 0.05; 2 tailed t test).
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EMSA and super shift analysis to assess binding of AP-l nuclear proteins to AP-llike elements in the proximal promoter of Aldhlal gene
We next wanted to establish whether AP-l proteins bind to these putative AP-llike elements at sites Band C by EMSA. The nuclear extract isolated from HepG2 cells
transfected with plasmid encoding c-Jun (Figure 27) was incubated with biotin-labeled
double-stranded probes containing AP-l-like elements Band C. We observed formation
ofa DNA-protein complex when labeled probe spanning AP-l-like element B was
incubated with nuclear extract but not with site C (Figures 28, 29 and 30). The specificity
of nuclear proteins binding to the AP-l-like element B was examined by competition
with cold unlabeled WT probe and unlabeled mutant p~obe containing mutations at the
AP-l-like element at site B. The nuclear proteins present in HepG2 cells overexpressing
c-Jun were allowed to form complexes with unlabeled WT (25- to 100-fold) or mutant
probe (lOO-fold) prior to the incubation with biotin-labeled probes spanning AP-l-like
element at site B. The results demonstrate that 100-fold excess concentration of unlabeled
WT probe completely competed with the biotin-labeled probe containing site B for AP-l
binding proteins (Figure 28). Thus, excess unlabeled specific WT probe completely
inhibited the formation of complexes with the biotin-labeled probe containing AP-l
element at site B. However, pre-incubation with unlabeled mutant probe only slightly
competed with the biotin-labeled AP-IB site for protein binding (Figure 29). We then
examined whether an increase in the concentration of nuclear extracts might result in
protein binding to biotin-labeled probe generated from AP-l-like element at site C.
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Figure 27. Western blots indicating over-expression of c-Jun in the nuclear extracts of
HepG2 cells. Nuclear extracts were prepared from HepG2 cells transfected with either
pcDNA3.1 (vector control; 2 flg/well) or pcDNA3.1-c-Jun (c-Jun expression plasmid; 2
flg/well) for 48 h using NE-PER nuclear and cytoplasmic extraction reagents (Pierce,

Rockford, IL) according to standard protocol. 48 h after transfection cell extracts were
separated on SDS-PAGE gel and transferred onto nitrocellulose membranes. The
membranes were probed with antibodies against c-Jun (1: 1000; sc-45) and GAPDH
(1 : 10000). Western blot experiment was performed in triplicate and the figure is a
representative blot.
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Figure 28. EMSA analysis indicates the formation of nuclear protein complex with the
AP-l-like element at site B (-758) but not with the AP-1-like element at site C (-1069).
Biotin-labeled double stranded probes were incubated with 5 Ilg of nuclear extracts from
HepG2 transfected with c-Jun expression plasmids for 20 min. In the competition
experiments, 25-1 OO-fold excess of unlabeled double stranded probes was included in the
binding reactions. The protein-DNA complexes were resolved by electrophoresis on 6%
precast DNA retardation gel and the binding reactions were then electrophoretically
transferred onto a nylon membrane. The immobilized biotin-labeled DNA was then
detected using the Chemiluminescent Nucleic acid detection kit. The result shown in this
figure was identical to that of three other independent experiments.
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Figure 29. The nuclear protein complex with the AP-l-like site at B (-758) was competed
by excess unlabeled wild type probe but not probe containing mutation in the AP-l-like
element. The specificity of binding to the AP-l site at B was further confirmed with 100fold excess of unlabeled double-stranded probe with mutations at the AP-l-like site at B.
EMSA was performed with nuclear extracts from HepG2 cells over-expressing c-Jun as
in Figure 28. The result shown in this figure was essentially identical to that of three
other independent experiments.

117

However, EMSA result shown in Figure 30 indicate the absence of nuclear protein
complex at the AP-l-like element at site C even when incubated with high concentration
of nuclear extracts (10 Ilg) from c-Jun overexpressing HepG2 cells. These results indicate
that the nuclear proteins do not form complexes with the AP-l-like element at site C.
To identify the composition of the nuclear proteins that form complexes with the
AP-l-like element at site B, super shift assays were performed by incubation of proteinDNA complex with antibodies against c-Jun, c-fos or Nrf2 at 4°C for 30 min (Figure 31).
Incubation of nuclear protein-DNA complexes with antibodies against c-Jun but not c-fos
or Nrf2 blocked the formation of the nuclear protein-DNA complex. The absence of
nuclear protein complex with AP-l site B instead of a super shift might be as a result of
the 6% polyacrylamide gel used in our experiment. The antibody-nuclear protein-DNA
complex may be too large to get into the gel. Future experiments will examine whether
this problem can be resolved by using lower % gels, such as 4-5% gel with a longer run
time. Moreover, the absence of nucleoprotein complex at site B might also be due to cJun antibody binding to the DNA-binding domain ofthe c-Jun, thereby blocking the
interaction between c-Jun and DNA.
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Figure 30. EMSA analysis indicates no protein binding to the AP-1 site C (-1069) at
higher concentrations of nuclear extracts. The experiment was performed essentially as in
Figure 28 . However, biotin-labeled double stranded probes were incubated with 10 f.lg of
nuclear extracts for 30 min. The figure is a representative of three other independent
experiments.
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Figure 31. Super shift analysis confirms that a protein in the nuclear extract that binds to
the AP-1 site B is c-Jun and not c-fos or Nrf2. EMSAs were performed by incubating
nuclear extracts from HepG2 cells transfected with c-Jun encoding plasmids with biotin
labeled probe containing AP-1 B site of the mouse Aldh1 a1 promoter. In super shift
experiments, the nuclear extracts were incubated with rabbit polyclonal c-Jun, c-fos and
Nrf2 antibodies for 30 min at 4°C prior to incubation with the labeled probe. The figure is
a representative ofthree other independent experiments.
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ChIP experiment to assess in vivo binding of nuclear proteins to putative AP-l sites
in the proximal promoter of Aldhlal gene
To investigate the functional importance of the AP-1-like sequences at sites Band
C in the proximal promoter of Aldh1a1 gene, ChIP experiment was used to assess
whether BHA promotes recruitment of c-Jun to these putative AP-1 binding sites at B and
C. Using c-Jun or c-fos antibodies, the complexes containing cross-linked AP-1 proteins

to the cognate AP-1 elements were pulled down from chromatin extracts prepared from
the liver of control or BHA-treated mice. The DNA fragments were then analyzed by
qRT-PCR with primers spanning the AP-1-like elements at B or C in the proximal
promoter of Aldhl al gene. As shown in Figure 32, liver extracts from BHA-treated mice
showed;:::; 10-fold increase recruitment of c-Jun to AP-1-like element at site B compared
to IgG control. The recruitment of c-fos to the AP-1 element at site Bin BHA-treated
mice though higher than in control mice was comparable to that of IgG control. These
results confirm that BHA promotes enhanced binding of c-Jun to the AP-1 B site in the
proximal promoter of Aldh1a1, which is associated with increased transcription. The
recruitment of c-Jun to AP-1-like element at site C was similar to that of site B. However,
this result differs from our EMSA experiment, demonstrating the absence of nuclear
protein complexes with the AP-1-like sequence at site C. This disparity might be due to
the close proximity of the AP-1-like elements at B and C, which are only 300 bp. The
sonication method employed for DNA shearing in the ChIP experiment generated DNA
fragments of;:::;500 bp. Thus, inefficient shearing of the DNA could produce a single
DNA fragment containing both AP-1-like elements.
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Figure 32. ChIP analysis to examine in vivo binding of c-Jun and c-fos to the AP-1 at
sites Band C. Chromatin were prepared from the liver of control or BHA-treated
mice. The complexes containing cross-linked DNA binding proteins to their cognate
cis-element were pulled down with antibodies against IgG, c-Jun or c-fos conjugated
to Dynabeads protein A/G. The purified DNA was analyzed by real-time PCR with
primers spanning AP-1 sites B in the proximal promoter of Aldh1a1 gene.
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DISCUSSION
Due to the potential metabolism, electrophile detoxification and anti-apoptotic
role of Aldhlal in mouse liver, an understanding of the molecular mechanism underlying
Aldhlal regulation is of utmost importance, and could be of therapeutic importance in
prevention of oxidative stress-induced pathologies. Aldhlal gene expression is
modulated by electrophiles, such as acrolein and BRA, which are associated with
enhanced expression of Aldhl al gene and transcriptional activation of c-JunJAP-l.
Transient transfection studies in RepG2 demonstrate that Aldhlal gene is activated by cJun homodimers, but not by c-Jun/c-fos heterodimers. The transcription factors, Nrf2 and
NF -KB were not involved in electrophile-induced transcription of Aldhl al gene. Previous
studies indicate that the up-regulation of cytoprotective genes by electrophiles are
mediated by enhanced recruitment of redox-sensitive transcription factors to the cisresponsive element in the promoter of these genes. The up-regulation of CYP2J2 gene
transcription by BRA is dependent on the binding of c-Jun and Nrf2 to an atypical AP-llike element in the proximal promoter ofCYP2J2 (Lee and Murray, 2010). The induction
of rat glutathione synthetase gene expression by tBRQ is mediated by a regulatory
element composed of two adjacent AP-l-like binding sites and is transactivated by the
AP-l complex (Yang et aI., 2002). In addition, JunD up-regulates the expression of the
human ferritin gene by oxidative stress via an ARE enhancer containing two AP-l motifs
located at -4.5 kb upstream region of the human ferritin R gene (Tsuji, 2005).
The deletion of the region between -1496 to -480 bp ofthe 5 'flank of Aldhlal
gene relative to the transcription start site completely abolished transactivation by c-Jun.
Analysis of this region by Genomatrix software indicates the presence of two AP-l-like

123

elements at positions -1069 (site C) and -758 (site B). The sequence of the AP-1-like
elements at position -758 (ATGATTCA) and -1069 (GCTCAGTCA) contains a single
nucleotide mismatch with the AP-1 consensus TGAG/CTCA found in the human
collagenase gene. The difference in the AP-1 motifs between Aldh1a1 and human
collagenase gene could explain the differential regulation of these genes by AP-1
complexes. While the collagenase gene is regulated by c-Jun/c-fos heterodimer, Aldh1a1
gene expression is mediated by c-Jun homodimer. The mutation of the AP-1 sequence at
position -758 significantly impaired c-Jun-mediated transactivation of Aldh1a1 reporter
activity. However, the activation of Aldh1a1 activity was modestly affected by
mutagenesis of the AP-1-like sequence at positions -1069, while mutation of both AP-1
sites completely abolished c-Jun-dependent transactivation. Thus, transient transfection
studies indicate that both AP-1-like elements are important for c-Jun-mediated activation
of Aldh1a1 reporter activity with the AP-1-like motif at position -758 playing a more
critical role.
EMSA and super shift analysis demonstrate the presence of c-Jun, but not c-fos or
Nrf2 in the nuclear protein complex bound to the AP-1 like sequence at -758, suggesting
the importance of AP-1 sequence at -758 in c-Jun-mediated activation of Aldh1a1 gene.
However, the AP-1 element at -1069 did not form protein complexes even when
incubated with high concentrations of nuclear extracts from HepG2 cells transfected with
c-Jun encoding plasmid. This observation is in contrast to the transient transfection
studies that showed mutation of site -1069 modestly decreased the activity of Aldh 1a1
promoter by c-Jun. The functional importance of the AP-1 sequence at -758 and -1069 in
electrophile-mediated activation of Aldh1a1 gene was tested by ChIP experiment. The
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binding of c-Jun to both AP-l elements at -758 and -1069 in the promoter of Aldhl al
gene was strongly increased by treatment of mice with BHA. The enhanced recruitment
of c-Jun to the AP-l element at -1069 by BHA is not consistent with the EMSA and
transient transfection studies. However, due to the proximity of the two AP-l sites, which
are less than 500 bp apart, it may be difficult to obtain DNA fragments with the separate
AP-l elements by sonication.
In summary, we describe an AP-l sequence at positions -758 that plays a critical
role in Aldhl al gene expression by electrophiles. The deletion and mutagenesis of this
AP-l-like sequence significantly abrogate activation of Aldhlal reporter activity by cJun. The formation of nuclear protein complex with the AP-llike sequence -758
containing c-Jun was detected by EMSA. BHA promotes binding of c-Jun to the AP-I
responsive sequence at -758 within the Aldhlal proximal promoter that regulates gene
expression. Transient transfection experiments also demonstrate that the AP-l like
sequence at -1069 plays a modest role in electrophile-induced expression of Aldhl al
gene.
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CHAPTER V
DISCUSSION AND CONCLUSIONS
Aldehydes generated by the process of lipid peroxidation are implicated in the
pathogenesis of several oxidative stress-associated pathologies, such as steatohepatitis,
liver fibrosis, atherosclerosis, myocardial ischemia-reperfusion injury, cancer and
cataractogenesis. Humans have elaborate systems to metabolize these toxic electrophiles
and prevent oxidative damage, including the aldehyde dehydrogenases superfamily of
enzymes. To date, the relative contribution of the different Aldh isozymes in cellular
detoxification of lipid aldehydes especially in mouse liver is highly controversia1.
Moreover, all previous characterization studies were done using rat cytosol with limited
or no studies in mice. Previous studies with human and rat ALDHs demonstrate that
ALDH3A1 but not ALDH1A1 provides protection against lipid derived aldehydes
(Townsend et a1., 2001). However, recent studies with Aldh1a1-1- mice showed that
ALDH1A1 has the potential to protect against these toxic species (Choudhary et a1.,
2005;Lassen et al., 2007). In chapter II, we presented ample evidence that Aldh1a1 plays
a major role in cellular defense against oxidative damage induced by reactive lipid
aldehydes in mouse liver. Aldh1a1 exhibits far higher affinity and catalytic efficiencies
for lipid aldehydes and OS-conjugates compared to Aldh2 or Aldh3a1. The endogenous
Aldh1a1 gene was highly expressed in mouse liver and liver-derived cell lines compared
to Aldh2 and Aldh3al. The knockdown of Aldh1a1 expression by siRNA caused
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Hepa-Iclc7 cells to be more sensitive to acrolein-induced cell death and resulted in
increased accumulation of acrolein-protein adducts and caspase 3 activation. Moreover,
previous studies demonstrate high levels of Aldhl al gene expression in the liver and lens,
two organs noted for generation of ROS and cytotoxic lipid aldehydes, suggest the
importance of Aldhl al in cellular protection against oxidative stress-induced damage.
These results indicate that mechanisms to induce the expression of Aldhl al gene in
mouse liver may be a useful strategy to prevent inflammatory diseases, such as the
progression of hepatic steatosis to steatohepatitis.
Microarray analysis of gene expression profiling in mouse liver by electrophiles
such as BHA or acrolein demonstrates the specific up-regulation of several antioxidant
and electrophile detoxification genes, including Aldhlal. QRT-PCR analysis confirmed
the activation of Aldhlal and other electrophile detoxification genes such as Nqo-l, HoI and Gstm I in mice liver by acrolein or BHA. These results are consistent with previous
studies that indicate that Aldhl al gene expression is induced by a variety of microsomal
enzyme inducers such as phenobarbital (PB) and BHA (Alnouti and Klaassen, 2008).
Consistent with the mRNA expression, the cytosolic Aldhlal activity was significantly
induced in mice liver treated with BHA or acrolein but not by SFN.
The signaling pathway involved in electrophile-mediated activation of Aldhl al
gene in mouse liver is unknown. One mechanism underlying electrophile-mediated
induction of Aldhlal gene expression can include electrophilic adduction to signaling
proteins involved in Aldhlal gene regulation. Electrophiles binding to keapl promote
Nrf2 nuclear localization and transactivation ofNrf2-responsive genes. However, while
BHA-induced expression ofNqol, Ho-l and Gstml genes in WT mice were significantly
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reduced in Nrf2-I - mice, Aldhlal gene was still responsive to BHA in Nrf2-I - mice liver
indicating that BHA-mediated activation of Aldhlal gene is independent ofNrf2. This
result is consistent with previous studies using Keap-l knockdown (keap l-kd) mice with
constitutively active Nrf2 (Reisman et aI., 2009). The mRNA expression ofNqol and
Gstml genes were significantly increased in keapl-kd mice compared to WT control,
suggesting that the inducible expression of these genes is Nrf2 dependent. However,
Aldhlal mRNA expression in keapl-kd mice liver was comparable to that ofWT mice,
confirming that electrophile-induced expression of Aldhlal gene is regulated by Nrf2independent mechanism. Even though the 5' flanking sequence of Aldhlal gene contains
numerous Nrf2-like binding sites (ARE), Nrf2 failed to stimulate the activity of Aldhlalluciferase reporter, which further supports our hypothesis that electrophile-induced
expression of Aldhlal gene is independent ofNrf2.
We hypothesized that electrophile-induced transcription of Aldhlal gene is
mediated by activation of AP-l gene. Previous studies demonstrate that the phenolic
electrophilic compounds and acrolein induce the expression of cytoprotective genes by
stimulating the expression and activity of AP-l proteins. The activation of c-JunlAP-l by
oxidative stress during acute hepatitis served a hepatoprotective function by
transcriptional up-regulation of Nos 2 gene (Hasselblatt et aI., 2007). JunD was recently
shown to regulate the human ferritin H gene expression involved in antioxidant defense
and protection against oxidative stress-mediated cytotoxicity (Tsuji, 2005). We showed
that the c-jun and c-fos mRNA expression were significantly increased by BHA or
acrolein in the livers ofWT mice and Hepalc1c7, which correlate with enhanced
Aldhlal mRNA expression. Furthermore, over-expression of c-Jun, JunD or JunB
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induced endogenous Aldhlal protein expression in mouse liver-derived cell lines. The
low basal expression of Aldhlal gene expression in Nrf2-I - mice could possibly be
attributed to reduced expression of c-Jun and c-fos gene in these mice. The
transactivation potential of c-Jun is enhanced by JNK mediated phosphorylation. BHA
and acrolein augments the protein levels and activity of c-Jun compared to control.
Moreover, the phosphorylation of c-Jun by acrolein correlates with the activation of its
upstream kinase, JNK. These results established that electrophile-induced transcription of
Aldhlal gene is mediated by enhanced expression and activity of AP-l genes. Transient
transfection analysis with c-Jun dominant negative proteins (TAM67) further confirmed
that activation of Aldhlal-Iuciferase reporter activity by acrolein is dependent on cJuniAP-l.
Lipid aldehydes contribute to the up-regulation of electrophile detoxifying genes
by modulating the activity of protein kinases, such as JNK, p38 and ERK (Wu et aI.,
2006;Zhang and Forman, 2008). Experiments using specific inhibitors of JNK, ERK or
MEKI revealed that the treatment of HepG2 with JNK (SP600l25) or ERKIMEKI
(PD98059) inhibitors block acrolein or c-Jun-mediated transactivation of Aldhlal
promoter activity. However, the phosphatase inhibitor (okadaic acid) significantly
increased Aldhlal promoter activity but had no effect on c-Jun-induced Aldhlal
luciferase activity. These results suggest that MAPK, such as JNK is essential for
transactivation of Aldhl al gene in HepG2 cells.
The AP-l proteins regulate gene expression as either homodimers of jun or
heterodimers with fos family. Transient transfection studies indicate that all the jun
family proteins (c-Jun, Jun D and Jun B) activate Aldhlal-Iuciferase reporter activity.
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We also noticed that while Fral and Fral had no effect on c-Jun-mediated transactivation
of Aldhlal-luciferase activity, over-expression of c-Fos inhibited activation of Aldhlal
reporter activity by c-Jun. Abrogation of c-Jun-dependent gene activation by c-Fos was
previously reported by Marden et aI., who demonstrated that whereas c-Jun homodimers
strongly activated CYP2J2 expression, heterodimers formed between c-Fos and c-Jun
were inactive (Marden et aI., 2003). Thus, mouse Aldhl al and human CYP2J2 genes
show similar pattern of regulation by AP-l with the predominant AP-l complex that
causes enhanced Aldhlal promoter luciferase activity being c-Jun homodimer and not cJun/c-Fos heterodimer.
Previous studies demonstrate that Nrf2 acts as a binding partner for c-Jun in
transcriptional activation of cytoprotective gene. For example, the activation of CYP2J2
gene expression by BHA dependent on functional interaction between c-Jun and Nrf2
(Lee and Murray, 2010). However, Nrf2 had no effect on c-Jun-mediated transactivation
of Aldhlal-Iuciferase activity. Electrophiles, such as acrolein and HNE have been
reported to enhance the expression of cytoprotective genes by activation of nuclear factor
KB (NF-KB) transcription factor. TNFa is a pro-inflammatory cytokines stimulated by
cytotoxic aldehydes and a known activator of the NF-KB signaling pathway. While TNFa
treatments did not activate Aldhlal-luciferase activity, it inhibited c-Jun-mediated
activation of Aldhlal-luciferase activity, suggesting that NF-KB activation abrogates cJun-induced activation of Aldhlal activity. This is consistent with in vivo results in
mouse liver which demonstrate that activators ofNF-KB signaling pathway such as high
fat diet causes significant reduction in Aldhl al gene expression.
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The mechanism by which AP-1 proteins modulate Aldh1a1 gene expression by
electrophiles is still unknown. Previous studies demonstrate that the up-regulation of
CYP2J2 gene transcription by BHA was dependent on the binding of c-Jun and Nrf2 to
an atypical AP-l-like element in the proximal promoter ofCYP2J2 (Lee and Murray,
2010). Analysis of the 5' -flanking sequence of Aldh 1a 1 gene indicates the presence of
four AP-1-like elements. The promoter deletion and mutagenesis studies indicate that two
AP-1-like elements between -1496 to -480 bp of the 5'-flank of Aldh1a1 gene relative to
the transcription start site are important for c-Jun-mediated activation of Aldh1a1 reporter
activity with the AP-1-like motif at position -758 playing a more critical role.
EMSA and super shift analysis demonstrate the presence of c-Jun, but not c-fos or
Nrf2 in the nuclear protein complex bound to the AP-1 like sequence at -758, suggesting
the importance of AP-1 sequence at -758 in c-Jun-mediated activation of Aldh1a1 gene.
The AP-1 element at -1069 apparently did not form protein complexes with extracts from
HepG2. This observation contrasts our mutagenesis studies which demonstrate that the 1069 site modestly affect c-Jun-mediated transactivation of Aldh1 a1 promoter. The in
vivo binding of c-Jun to both AP-1 sequences at -758 and -1069 was strongly increased

by treatment of mice with BHA detected by ChIP experiment. However, the enhanced
recruitment of c-Jun to the -1069 site by BHA might be due to close proximity «500 bp)
between this site and the -758 site, it may be difficult to obtain DNA fragments with the
separate AP-1 elements by sonication. Future ChIP experiment where the chromatin is
fragmented by enzymatic digestion using micrococcal nuclease will allow one to examine
whether BHA promotes binding of c-Jun to both AP-1 sites.
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In conclusion, we showed that Aldhlal has both electrophile detoxification and
antiapoptotic roles in mouse liver and liver-derived cell lines. We also have provided
evidence that Aldhlal gene can be induced by electrophiles such as acrolein and BHA
and that increased expression of Aldhlal gene by electrophiles was dependent on cJuniAP-l and not Nrf2 or NF-KB. Aldhlal gene expression was modulated by c-Jun

homodimer and not c-Jun/c-fos heterodimer. The MAPK especially JNK also plays a
crucial role in electrophile mediated activation of Aldhlal gene. The deletion and
mutagenesis of two AP-l-like sequences at positions -758 and -1069 significantly
abrogate activation of Aldhlal reporter activity by c-Jun. The formation of nuclear
protein complex with the AP-llike sequence -758 containing c-Jun was detected by
EMSA. BHA promotes binding of c-Jun to the AP-l responsive sequence at -758 within
the Aldhlal proximal promoter that regulates gene expression. Due to the lipid aldehyde
detoxification and anti-apoptotic role of Aldhlal in mice liver, an understanding of the
mechanism to activate Aldhlal gene expression might provide a useful rationale for
therapeutic protection and amelioration of oxidative stress-induced pathologies. The
proposed model for the activation of Aldhlal transcription by electrophiles is illustrated
in Figure 33.
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Figure 33. Proposed schematic model for the activation of Aldhlal gene by electrophiles.
Electrophiles such as BHA and acrolein are known to induce oxidative stress in cells by
redox cycling and depletion of cellular reduced GSH, respectively. In response to
oxidative and electrophilic stress, stress-activated protein kinase such as JNK
phosphorylates c-JunIAP-l and enhances its trans activating potential. There is enhanced
recruitment of c-Jun homodimer to AP-l-like element in the proximal promoter of
Aldhlal gene resulting in transcriptional activation of Aldhlal gene. Increased
expression of Aldhlal leads to enhanced metabolism and detoxification of acrolein and
HNE, thereby inhibiting the progression of fatty liver to steatohepatitis (NASH).
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FUTURE STUDIES.
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of pathologies ranging
from simple triglyceride accumulation in hepatocytes (simple steatosis) to steatosis with
inflammation (steatohepatitis, NASH), fibrosis, cirrhosis and hepatocellular carcinoma
(Browning and Horton, 2004). Hepatic steatosis is benign and reversible. However,
formation of NASH may progress to fibrosis and other end-stage liver diseases. The
prevalence ofNAFLD in the general population is estimated to be between 14-24% with
::::;30 million Americans affected with the disease. Cirrhosis ofthe liver accounts for 14%
of liver transplants in the US. The "two hit model" was proposed to explain the etiology
ofNAFLD (Day and James, 1998). The "first hit" is attributed to insulin resistance,
which leads to simple steatosis. The "second hit" is due to oxidative stress, which might
be a consequence of increased production ofROS in the liver, relative to antioxidants,
generated from activation of alternative pathways for fatty acid oxidation such as the
peroxisomal

~

oxidation and microsomal ro oxidation catalyzed primarily by acyl-CoA

oxidase and cytochrome P450 4A, respectively. ROS are relatively short-lived and exert
local effects. However, they initiate lipid peroxidation in cells by attacking PUF A, which
results in formation of aldehyde products such as acrolein, HNE and MDA (Esterbauer et
aI., 1991). These aldehydes have longer half-lives than ROS and can diffuse to distant
sites of their production, thereby amplifying the effects of oxidative ROS. It is proposed
that the deleterious effect of ROS is mediated by these aldehydes (Esterbauer et aI.,
1991;Esterbauer, 1993).
Reactive aldehydes are implicated in the initiation and perpetuation of
inflammation in NASH. The accumulation of reactive aldehydes in the liver can promote

134

the influx of inflammatory cells by stimulating the production of the proinflammatory
cytokines, TNFu, thereby amplifying inflammatory response (Browning and Horton,
2004;Esterbauer et ai., 1991). In addition, reactive aldehydes are also known to activate
hepatic stellate cells leading to collagen deposition (Browning and Horton, 2004). Thus,
lipid aldehydes can promote progression from steatosis to NASH by directly inducing
hepatocyte death and necrosis, inflammation and liver fibrosis. We showed that Aldh1al
is a major enzyme in mouse liver involved in oxidative metabolism and detoxification of
lipid aldehydes. Thus, we hypothesize that activation of Aldhla1 gene expression in the
liver is a therapeutic strategy to prevent progression to NASH. Future experiment should
examine whether Aldh1a1-1- mice are more susceptible to NASH than WT mice on long
term high fat diet (HFD), a standard nutritional method for stimulating NAFLD and
NASH in rodents (Kim et aI., 2004). Male C57BLl6 (WT) mice and Aldh1al-l - mice on
C57BLl6 background could be placed on low fat diet (LFD) or HFD for 12 weeks.
Subsequently, the liver can be examined for lipid accumulations using Hand E staining.
Markers of oxidative stress can be examined, such as total, reduced (GSH) and oxidized
(GSSG) glutathione, and aldehyde accumulations in the liver. Finally, the levels of proinflammatory cytokines, such as TNF u, IL-1 ~ and Cox2 can be compared in both
genotypes. Aldh1a1 gene expression is induced in mice liver by phenobarbital (PB)
(Alnouti and Klaassen, 2008). Future studies could also assess whether activation of
Aldhla1 gene expression in the liver by PB can prevent NASH. C57BLl6 mice can be
administered either saline or 100 mg/kg PB (i.p) in saline daily for 7 days. The markers
of oxidative stress and aldehyde accumulation, pro-inflammatory cytokines and lipid
accumulations can be assessed in control and treated group of mice.
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APPENDIX
LIST OF ABBREVIA nONS
4-HNE: 4-hydroxy-2-nonenal
Acrolein: propen-2 al
AP-1: Activator protein 1
Aldh: aldehyde dehydrogenases
LPO: Lipid peroxidation
MDA: malondialdehyde
WT: wild type
ORF: open reading frame
CYP: Cytochrome P450
ROS: reactive oxygen species
MTT: 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis
AKR: aldoketoreductase
Nrf2: Nuclear factor-E2 related factor 2
ARE: Antioxidant response element
BHA: butylated hydroxy anisole
tBHQ: tert-butylhydroquinone
CAR: Constitutive androstane receptor
PB: Phenobabitals
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SFN: Sulforaphane
GSH: Glutathione
GST: Glutathione-S transferase
ADH: Alcohol dehydrogenase
GS-HNE: glutathione conjugate of 4-HNE
Keap-1: Ketch-like ECH-associated protein 1
NAD(P)+: Nicotine adenine dinucleotide phosphate, oxidized form
NF-KB: nuclear factor kappa B
PCR: Polymerase chain reaction
QRT-PCR: Quantitative real time PCR
RXR: retinoid X receptor
RAR: retinoic acid receptor
TPA: 12-0-tetradecanoyl-phorbol-13 acetate
TRE: TP A response element
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SUMMARY OF Ph.D DISSERTATION RESEARCH

Reactive lipid aldehydes are implicated in the pathogenesis of various oxidative
stress-mediated diseases, including the transition from hepatic steatosis to non-alcoholic
steatohepatitis (NASH). The role of Aldehyde dehydrogenase (Aldh) isozymes in
detoxification of lipid aldehydes, such as acrolein and HNE in mice liver is highly
controversial. The first part of my thesis was to define which hepatic Aldh isoforms plays
a major role in detoxification of lipid-derived aldehydes in mice liver by enzyme kinetics
and in vitro knockdown experiment. Kinetic studies revealed that Aldhlal exhibits
higher affinity for acrolein and HNE compared to Aldh2 and Aldh3al. We also
demonstrated that knockdown of Aldhlal expression by siRNA caused lipid-derived
cells to be more sensitive to acrolein-induced cell death, and resulted in increased
accumulation of acrolein-protein adducts and activation of caspase 3. These results
indicate that Aldhlal plays a major role in cellular defense against oxidative damage
induced by reactive lipid aldehydes in mouse liver. We also noted that hepatic Aldhlal
mRNA levels were significantly increased (;::: 3-fold) in acrolein-fed mice compared to
control. In addition, hepatic cytosolic ALDH activity was induced by acrolein when 1
mM NAD+ was used as cofactor, suggesting an Aldhlal-protective mechanism against
acrolein toxicity in mice liver. Thus, mechanisms to induce Aldhlal gene expression
may provide a useful rationale for therapeutic protection against oxidative stress-induced
pathologies.
The second part of my thesis was to decipher the mechanisms of electrophileinduced transcription of Aldhlal. We analyzed the mRNA levels of hepatic Aldhlal in
C57BL6 (WT) and Nrf2-I - mice exposed to butylated hydroxyanisole (BHA) by qRTPCR. In vivo, BHA is demethylated to tert-butylhydroquinone (tBHQ), which is known
to undergo redox cycling to tert-butylquinone (tBQ) generating ROS. BHA exposure
resulted in ~2-fold increase in mRNA levels of Aldhlal in WT and Nrf2-I - mice
compared to control of the same genotype, while the induction of Nrf2 target genes, such
as Nqo-l, Ho-l and Gstml upon BHA administration was significantly reduced in Nrf2-Imice. The mRNA and protein levels of the AP-l genes (c-Jun and c-fos) were
significantly induced by BHA treatment in WT mice. Transient transfection experiments
were conducted in HepG2 cells with Aldhlal 5'-flanking luciferase reporter vectors.
While co-transfection with Nrf2 expression plasmid had no effect, over-expression of cJun resulted in ;:::4-fold induction in Aldhlal transcriptional activity. We proposed that
electrophile-induced transcription of hepatic Aldhl al is mediated by c-Jun/AP-l. Overexpression of a dominant negative c-Jun (TAM67) protein in HepG2, treatment with 50
~M JNK (SP600125) or MEKI (PD98059) inhibitors significantly abrogate the
electrophile-mediated transcription of Aldhlal. We further showed that c-Jun induces
Aldhlal promoter activity as a homodimer and not as c-Jun/c-Fos heterodimer. Deletion
and mutagenesis studies established that two AP-l sites at position -758 and -1069
relative to Aldhlal transcription start site mediate c-Jun-induced transcription of
Aldhlal. We further confirmed that electrophiles promote the binding of c-Jun to the
proximal AP-l site by electrophoretic mobility shift assay (EMSA) and ChIP assay.
Taken together, these data suggest that Aldhlal may be a novel therapeutic target for
preventing the transition from fatty liver to NASH.
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